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ABSTRACT
CHARACTERIZATION OF THE BIOLOGICAL ACTIVITIES OF RECOMBINANT 
FUSION PROTEIN GREEN FLUORESCENT PROTEIN/HUMAN ZONA 
PELLUCIDA PROTEIN 3 (GFP/HZP3)
Zhiyong Lin
Eastern Virginia Medical School and Old Dominion University, 2001
Director: Dr. Ke-Wen Dong
Despite numerous reports indicating the successful production of bioactive 
recombinant ZP3, no report has shown the rhZP3 having direct binding activity 
with human sperm. Recombinant ZP3 generated from our previous study 
displayed binding activity with human sperm through indirect evidence from 
hemizona assay (HZA).
This present study focused on the production of recombinant ZP3 with 
direct binding activity with human sperm. Through the application of a pEGFP 
expression vector, fusion protein GFP/ZP3 was successfully generated and 
expressed. The expression of GFP/ZP3 was evidenced by RT-PCR and western 
blot. The fusion protein was partially purified by Ni-NTA affinity column from cell 
culture medium of stably transfected cells generated from a single cell clone. 
Immuno-blotting analysis of the fusion protein indicated that the GFP/ZP3 was 
about 90-92 kD in molecular mass which is close to the sum of the size of GFP 
and ZP3. Flow cytometry was conducted to evaluate the direct binding activity of 
fusion protein with human sperm. The GFP/ZP3 showed dose-dependence in 
the binding assay. GFP tag removal resulted in almost no detectable binding as 
assayed by flow cytometry, thereby indicating that ZP3 binding was specific. 
Furthermore, immunofluorescence demonstrated that the fusion protein
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interacted with human sperm on the acrosome region. In the acrosome reaction 
assay, fusion protein was proved to be able to induce the sperm acrosome 
reaction (19.2% ± 3.4% as compared to basal line 10.8% ± 2.3%) at the 
concentration of 1ug/ml. Therefore, the fusion protein displayed full spectrum 
biological activity of ZP3, and, most importantly unlike prior studies, this binding 
activity was elucidated in a direct way.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGEMENTS
I wish to appreciate my advisor, Drs. Ke-wen Dong and Sergio Oehninger, 
for their guidance, support, as well as patience in my PhD education and 
research. Also, I want to thank my committee members, Dr. Frank Castora and 
Dr. Michael Solhaug for their efforts in advising throughout the project, as well as 
Drs. Xi Jiang and Mark Elliott’s advice in my PhD studies.
Special thanks are extended to Dr. Albert kit Chan, Dr. Jr-Gang Cheng, 
Dr. Ting-Fung Chi, Dr. Ming-I Hsu, Dr. Ruizhi Liu, Dr. Heming Zheng, Hua Zhao, 
Deyu Wang, Wenxian Ji, Usa Kullaprawithaya for their support, cooperation, and 
friendship during my PhD studies.
Finally, I would like to dedicate this dissertation to my parents, my dear 
wife for their love and support.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
Page
LIST OF FIGURES -......... -.......... -........................................................................- vii
INTRODUCTION------------------------  —   - - - - 1
A. Formation and structure of spermatozoa -   — -........ 1
B. ogenesis and oocyte structure  -- -   - -   - 3
C. The sperm acrosome-------------------------  -  - - -........................-  4
D. Mammalian fertilization • - - - •• - 6
E. Sperm capacitation and acrosome reaction 7
F. Zona Pellucida  .... ....................................................................................11
G. ZP3 and its biological functions - •   15
H. Carbohydrates ....- - - 18
I. Putative zona binding proteins on sperm .................. - 20
J. Recombinant ZP3 production----------- 23
SPECIFIC AIMS--------------------   -.........-......................... 26
A. Significance of the proposed research -   26
B. Rationale of the proposed research project..................................................28
C. Specific aims  ----------- -........................................................................ 32
MATERIALS AND METHODS ------  -   35
A. Design and construction of oligonucleotide primers - - 35
B. Cell culture and medium collection    — ..............................  36
C. Subcloning of pEGFP-ZP3 plasmid construct - - - - ..............- 37
D. Ligation and transformation----------------  _ -  38
E. DNA isolation (mini prep.) --------  - •• - .............  40
F. Preparation of labeled probe for colony hybridization 41
G. Colony hybridization to identify the colony with B1B2 insert 42
H. Screen positive colony by PCR - 44
I. DNA isolation from transformed E. Coli. (max prep.) 44
J. Stable transfection......................................   45
K. Isolation of mRNA..........................    46
L. RT-PCR............................................ ............... ...................... -.......-.............-48
M. SDS-PAGE and Western blot analysis •• 49
N. BCA assay.............................................  -.................... -..................50
O. Protein purification by affinity chromatography - - 50
P. Preparation of motile sperm and spermatozoa capacitation 51
Q. Acrosome Reaction-----------------  -..................................................52
R. Using flow cytometry to test the binding activity of GFP/ZP3 — 53
S. Assessment of the binding GFP/ZP3 to human spermatozoa in
indirect immunofluorescent microscopy   ..................   54
permission of the copyright owner. Further reproduction prohibited without permission.
V I
RESULTS----------------------------------------------------------------------   56
A. Subcloning of human ZP3 cDNA sequence into pEGFP-C1 vector -  56
A1: Insertion of the oligo B1B2 into the pEGFP-C1 vector______  58
A2: Subcloning of ZP3 sequence without the signal sequence into 
pEGFP-B1B2 _____________________          _60
B. Stable transfection and expression of fusion protein GFP/ZP3 ............. 64
B1: Determination of the expression of GFP/ZP3 by flow
cytometry and fluorescence microscopy______________  64
B2: RT-PCR to identify the expression of fusion protein
GFP/ZP3 _________ ____ -.......... ..........._  ......    66
B3: Western blot using monoclonal anti-GFP antibody to 
demonstrate the expression of GFP/ZP3 protein  ........................ 68
C. Purification of fusion protein from cell culture medium ..............   70
D. Identification of purified protein using western blot by three
antibodies-------------------------------------------------------     -- -72
E. Characterization of the biological activities of the fusion
protein (GFP/ZP3) ............................................   _ .....  76
E1. Human sperm binding activ ity__________________     78
a. Flow cytom etry_______________    78
a1. Sperm binding time course study.  ------- - 78
a2. Dose dependency test ---------------- —---------------- 80
a3. Effect of enterokinase digestion of fusion protein
on sperm binding te s t-----------------------    -...... 82
b. Immunofluorescence microscopy to identify sperm 
binding _________________       88
E2. Acrosome reaction induced by fusion protein GFP/ZP3 ........  88
DISCUSSION-----------------------------    - ----------  -  -......91
CONCLUSIONS_______________ ——-------------------------------------------------  4 04
REFERENCES...................................... ................. ......................-...................... 105
VITA_____________________________      - .-.-.........— .-..114




1. Human ZP3 sequence and the position of the primers in the study 39
2. The strategy of subcloning ----   - ........... - -..... —  57
3. Step I construct and screening positive colony by colony hybridization 59
4. Confirmation of the insertion of B1B2 by restriction digestion with Nhel
and X ho l  ....................................................           61
5. Step II construct and the determination of the insertion of ZP3 cDNA
by PCR — ......      —................. -.....................-...................63
6. Determination of the expression of GFP/ZP3 by flow cytometry
and fluorescence microscopy    -  65
7. Verification of the expression of fusion protein EGFP/ZP3 in stable 
transfected PA-1 cells with human ZP3/GFP cDNA by RT-PCR 67
8. SDS-PAGE and western blot of non-purified fusion protein sample 69
9. The sequential protein elute with different concentration of imidazole
from Ni-NTA column------------------------ -----— ................ -..... -.............. ...... 71
10. Purification of GFP/ZP3 by Ni-NTA affinity column 73
11. Identification of GFP/ZP3 by three antibodies - 75
12. Digestion of the purified fusion protein with Enterokinse Max......................77
13. Time course study of sperm binding with GFP/ZP3 — ...........................79
14. Dose dependency test of sperm binding with GFP/ZP3 - - ..................81
15.Enterokinase digestion of fusion protein vs sperm binding test 83
16. Determination of the effect of enzyme digestion buffer on sperm
binding---------------------------    -............. .....   -...-.......................... 84
17. Summary of enterokinase digestion vs sperm binding test . 86
18. Sperm binding test by flow cytometry_________    - ..................   87
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19. Immunofluorescence microscopy to identify GFP/ZP3 binding with human 
sperm______________________________________           89
20. Acrosome reaction induced by recombinant fusion protein GFP/ZP3 ~ 90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1
INTRODUCTION
Fertilization is defined as the process of the union of two germ cells, the 
egg and sperm, whereby the somatic chromosome number is restored and the 
development of a new individual exhibiting characteristics of the species is 
initiated. If fertilization fails to take place, both egg and sperm degenerate 
relatively rapidly in the female reproductive tract, since the two highly 
differentiated cells cannot survive long on their own. Among mammals, the 
process of union of germ cells includes several ordered steps (Wassarman, 
1987; Yanagimachi, 1994; Snell and White, 1996). It begins in the oviduct with 
binding of free-swimming sperm to the ovulated egg extracellular coat, the zona 
pellucida (ZP), and ends a short time later with fusion of egg and sperm plasma 
membranes to form a single “activated” cell, the zygote. Along the way, several 
recognizable events take place, including the sperm acrosome reaction (a form 
of cellular exocytosis), penetration of the egg ZP by sperm, and the egg cortical 
reaction and zona reaction. The latter results in alteration of the ZP such that 
free-swimming sperm are unable to penetrate the egg.
A. Formation and structure of spermatozoa
Throughout postpubertal male reproductive life, spermatozoa are formed 
from spermatogonial stem cells by a highly orchestrated process referred to as 
spermatogenesis. The entire process consists of three sequential phases of cell 
proliferation and differentiation. First, there is an extensive multiplication and
Model journal used in this dissertation was Molecular and Cellular Endocrinology.
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proliferation of spermatogonial stem cells to produce an optimal number of 
spermatogonia which give rise to primary spermatocytes and also to maintain a 
pool of stem cells. Second, the primary spermatocytes undergo a lengthy meiotic 
prophase, followed by the first meiotic division resulting in the formation of two 
secondary spermatocytes, each undergoing the second meiotic phase to 
produce four haploid round spermatids. Finally, there is a gradual remodeling of 
the nuclear and cellular components of round spermatids during transformation 
into sperm cells by a process referred to as spermiogenesis (Eddy et al., 1994). 
Sperm development takes place within the germinal epithelium of the 
seminiferous tubules where germ cells are arranged along the wall of tubules in a 
well-defined combination of various developmental stages. Due to continuous 
maturation of the testicular germ cells from each generation of cells, the 
combination of cells varies along the length of the tubule. The well programmed 
multiple changes occurring between the appearance of one pattern and its 
reappearance in a different segment of a given tubule is defined as the “cycle of 
the seminiferous epithelium” (Clermont, 1972).
The normal human spermatozoon is morphologically divided into two 
parts, head and tail. The sperm head has a flattened, pyriform shape, it 
condensed nuclear chromatin, and acrosomal cap has a length of approximately 
5 to 6 pm and a width of 2.5 to 3.5 pm. The head is divided into the acrosomal 
and postacrosomal regions. The acrosomal region is covered by the plasma, 
outer acrosomal, inner acrosomal, and nuclear membranes. The postacrosomal 
region and neck connects the head to the middle piece. The tail or flagellum
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allows motility in a vibratory, circular, or linear manner. The tail has three 
regions: a middle piece, a principle piece, and an end piece of variable length. 
The middle piece has a core of flagellum, surrounded by mitochondria. In cross 
section the flagellum has an axoneme, a central pair of single microtubules 
surrounded by nine doublets. The end piece is a short segment that lacks any 
components other than the axoneme and the plasma membrane.
B. Oogenesis and oocyte structure
The task of oogenesis is to construct a large cell containing a large and 
complex dowry of resources for construction of the embryo before it can either 
make them on its own or obtain them from its environment. Oogenesis begins 
with primordial germ cell formation and encompasses a series of cellular 
transformations, from primordial germ cells to oogonia, from oogonia to oocytes 
and from oocytes to egg. Oogonia can undergo mitotic divisions, but then stop 
dividing. In the human female, millions of oogonia are produced during the 
second and seventh months of fetal life. Most of these primary oocytes die, 
others enter the first meiotic prophase -  chromosomes replicate and pair. There 
is a continuing atresia during human development, by puberty, only about 
300,000 follicles remain, they are in a state of arrested Prophase I and will not 
begin maturing until puberty. In the human female primary oocytes remain in 
meiotic prophase until puberty. Only one of these primary oocytes per menstrual 
cycle normally undergoes further changes and mature each month. The primary 
oocytes (1° oocyte) (4n) are within a follicle. Cortical granules form as does the
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egg coat after completion of meiosis I. There are two different "cells," the 
secondary oocyte (2° oocyte) (2n) and the first polar body. This is due to uneven 
cytokinesis at the end of meiosis I. The first polar body can go on to undergo 
meiosis II to form two more polar bodies. The secondary oocyte undergoes 
meiosis II only after fertilization, converting the 2° oocyte into an egg (and a 
second polar body). The oocyte measures about 120pm in diameter in human, it 
is a highly specialized cell. The oocyte is surrounded by a transparent non- 
cellular membrane, the zona pellucida, and a layer of follicular cells, the corona 
radiata and cumulus cells, immediately underneath the zona pellucida is the 
perivitelline space followed by the plasma membrane. The yolk made up of 
glycogen, lipids and proteins provides nutrients for the oocyte. Some are 
produced by the oocyte, others are synthesized elsewhere (liver) and transported 
to the oocyte. Oocytes accumulate components, in the form of mRNAs and 
proteins for translational machinery, DNA replication machinery, energy systems, 
cytoskeleton, metabolism etc. As a consequence, in most species, enucleated 
fertilized egg can proceed through some cell cycles. Transcription is initially not 
necessary during early development. Translation is, on the other hand, one of the 
first processes to be activated after fertilization.
C. The sperm acrosome
The sperm acrosome is a Golgi-derived structure forming a cap over the 
anterior region of the nucleus, which contains many hydrolytic enzymes and 
consists of an anterior cap and a posterior region called the equatorial segment.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5
The acrosome plays an important role at the site of sperm-zona (egg) binding 
during the fertilization process. Clinical studies have identified a distinct group of 
men whose infertility is associated with abnormal acrosome reaction (Benoff, et 
a!., 1997). The organelle is a Golgi-derived secretory granule, which is formed 
during an early stage of spermiogenesis. It resembles the cellular lysosome, a 
bag-like structure that normally functions in intracellular digestive and defensive 
mechanisms. The sperm acrosome is a sac-like structure surrounded by inner 
and outer acrosomal membranes. Immediately after sperm (receptor)-zona 
(ligand) binding, at least in the mouse, the outer acrosomal membrane fuses with 
the overlying plasma membrane, releasing the acrosomal contents 
(glycohydrolases, proteases, etc.) at the site of sperm-egg binding (acrosomal 
exocytosis). The acrosome is formed during spermiogenesis and represents one 
of the defining features of sperm development in the testes. At the beginning of 
spermiogenesis, meiosis is complete and the nondividing haploid cells begin to 
transform into a uniquely shaped spermatozoon which takes 12-14 days for 
completion. The Golgi complex at an early stage of spermiogenesis (round 
spermatid) consists of a prominent system of closely packed tubules and vesicles 
localized close to one of the poles of the nucleus. Some of these vesicles enlarge 
and become filled with dense, fine granular components that migrate and empty 
their glycoprotein- rich contents into the forming acrosome system (head cap and 
acrosome). The vesicles that contribute to the acrosome formation are derived 
from the trans-Golgi stacks. The shape of the acrosome is quite variable between 
species, ranging from skull-cap in man to sickle-shape in rodents (Eddy et al.,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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1994; Clermont et al., 1993). Modifications, such as condensation of the 
acrosome and intra-acrosomal modifications of several antigens are completed 
as the spermatozoa transit through the epididymis. The sperm acrosome 
contains a variety of acid glycohydrolases, proteinases, phosphatases, 
esterases, and aryl sulfatases.
O. Mammalian fertilization
The final steps of spermatogenesis and oogenesis produce sperm and 
eggs respectively, that will be available for fertilization. Mammalian fertilization is 
the net result of a complex set of molecular events in which capacitated 
spermatozoa bind to the homologous egg and undergo several programmed 
events before penetration of the zona pellucida and fusion with the egg. 
Fertilization is defined as the process of union of two germ cells, egg and sperm; 
complementary molecules on the surface of sperm and eggs are responsible for 
interactions between gametes during the course of fertilization (Farley, 1982). 
There are highly orchestrated events involved in the interaction between 
mammalian gametes. The major events include gamete maturation, regulated 
sperm transport, sperm-oocyte recognition, sperm-zona penetration, and sperm- 
oocyte fusion.
Sperm maturation involves capacitation and acquisition of a hyperactive 
state, and expression of cell-cell adhesive ligands. Upon ejaculation and 
residence in the female reproductive tract, mammalian spermatozoa bind to 
oviduct cells; after undergoing capacitation, sperm pass through the enveloping
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cumulus oophorus, which is composed of a glycosylaminoglycan matrix and 
cumulus cells, then the primary binding occur between the extracellular matrix 
called zona pellucida on the egg and the sperm, which is a species-specific 
event, results in sperm activation and induction of acrosome reaction, the latter 
facilitates secondary binding to the zona. Only acrosome-intact sperm can bind 
to the ovulated eggs in mouse and possibly in human. Proteolytic and hydrolytic 
enzymes released during the course of the acrosome reaction then facilitate the 
penetration of the fertilizing sperm through the ZP and into the perivitelline space. 
Then spermatozoa enter into the perivitelline space, bind to the egg plasma 
membrane and fuse with it. Following fusion of the sperm head and oolemma at 
discrete sites, sperm and egg pronuclei are formed, and fusion of both pronuclei 
results in the completion of fertilization. This is followed by nuclear 
decondensation and activating zygote development. Immediately after 
fertilization, two important changes contribute to prevent polyspermy: the zona 
pellucida is biochemically modified, and also a rapid electrical depolarization of 
the egg plasma membrane blocks additional sperm in the perivitelline space from 
fusing with the egg.
E. Sperm capacitation and acrosome reaction
Although the spermatozoa are “mature” when they leave the epididymis, 
nevertheless, their activity is still held in check by multiple inhibitory factors 
secreted by the genital duct epithelia. Therefore, when they are first expelled in 
the semen, they are still unable to perform their duties in fertilizing the ovum.
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However, on coming in contact with the substances/fluids of the female genital 
tract, multiple biochemical and functional modifications occur, which are 
collectively called capacitation of the spermatozoa. This process will then enable 
the binding of sperm to zona pellucida of the ovum more feasible which 
subsequently leads to fertilization. The net change during capacitation is a 
combined effect of multiple molecular modifications in sperm plasma membrane 
proteins/glycoproteins and lipid components that modify the ion channels in the 
plasmlemma of spermatozoa. The preparatory modifications include removal of 
seminal plasma proteins adsorbed to the surface of ejaculated spermatozoa and 
reorganizations/modifications of sperm surface molecules (Yanagimachi, 1994). 
The molecular mechanisms underlying the functional changes are not fully 
understood. As capacitation proceeds, a number of biochemical changes allow 
the transmembrane flux of ions that are believed to be important in initiating the 
events of capacitation, hyperactivation, and acrosome reaction. Only capacitated 
spermatozoa are able to recognize and bind to the ZP (Yanagimachi, 1994).
As a result o f these modifications, spermatozoa become acrosomally 
responsive by an unknown mechanism. Evidence from several studies suggests 
that the sperm plasma membrane loses cholesterol before becoming 
acrosomally responsive (Cross, 1998). Although the importance of capacitation 
has been known for nearly 40 years (Yanagimachi, 1994), the molecular 
mechanisms underlying the functional changes are not fully understood.
Capacitation and hyperactivation take place before sperm-zona (egg) 
interaction, and the latter event, at least in mouse and several other species
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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including man, is initiated after sperm-egg interaction. It is, therefore, reasonable 
to assume that these events are independent and involve regional-specific 
changes in sperm plasma membrane. All mammalian spermatozoa undergo 
capacitation after residing in the female genital tract. Similarly, spermatozoa 
recovered from the female genital tract after mating, or ejaculated spermatozoa 
following incubation with the cumulus masses and oviductal secretions, are able 
to fertilize an egg in vitro, a result consistent with the suggestion that these 
sperm have undergone capacitation (King et al., 1994). Mammalian spermatozoa 
can also be capacitated in vitro in a chemically defined medium containing 
bovine serum albumin and energy substances, such as glucose and pyruvate, as 
well as components used in Krebs-Ringer bicarbonate medium (Dow et al., 
1989). It is noteworthy that albumin is the major protein in female genital tract 
secretions and is an important component during in vivo and in vitro capacitation 
(Dow et al., 1989). Kopfs lab has showed the essential role of bicarbonate ion, 
albumin and cAMP in the sperm capacitation in mouse, hamster, bovine and 
human (Galantino-Homer et al, 1997; Visconti, eta l., 1995, 1998, 1999; Osheroff 
et al., 1999). The protein facilitates capacitation by efflux of fatty
acids/cholesterol from sperm plasma membrane. The loss of fatty
acids/cholesterol increases fluidity and permeability of the sperm plasma
membrane, initiating the events of capacitation and the acrosome reaction
(Cross, 1998).
Acrosome reaction (AR) is an exocytotic process physiologically induced 
by ligand (ZP3)-receptor interaction, consisting in multiple fusions between outer
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1 0
acrosomal membrane and the overlaying plasma membrane leading to the 
release of acrosomal enzymes and exposure of the molecules present on the 
inner acrosomal membrane surface that mediate fusion with oolemma. As 
mentioned above, only capacitated sperm are physiologically able to undergo AR 
in response to physiological stimuli. It is thus conceivable that the two process, 
capacitation and AR, are sequentially and functionally linked such that several of 
the effectors involved in mediating intracellular signaling activated by AR start to 
be tuned during capacitation. For instance, the increase of intracellular calcium 
levels and tyrosine phosphorylation of proteins accompanying capacitation is 
also essential for the subsequent exocytosis in response to P4. The process of 
AR consists of development of multiple fenestrations between the outer 
acrosomal membrane and the plasma membrane of the spermatozoa leading to 
the release of the enzymatic content of acrosome and to the exposure of the 
enzymes bound to the inner membrane adjacent to the nuclear envelope. In the 
absence of any specific stimuli only a low percentage of human spermatozoa can 
undergo AR. It has been suggested that self-aggregation of the sperm receptor 
for ZP may account for this spontaneous acrosome reaction. A wide variety of 
molecules present on sperm surface have been proposed as putative candidate 
for ZP3 receptor. This rather long list of possible candidates may be justified by 
the involvement of different receptors in different species or different binding 
affinities, or even multiple receptors that may cooperate in sequence to induce 
AR: however none of these molecules has been definitively recognized as "the 
sperm-egg receptor". AR can also be physiologically induced by P4, present at
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high levels in the cumulus matrix surrounding the oocyte that must be crossed by 
sperm to reach the zona pellucida. The steroid has been described to affect 
several other sperm functions, including capacitation, motility and priming effect 
on ZP3-induced AR through stimulation of a rapid nongenomic signaling pathway 
mediated by recently characterized P4 receptors present on sperm surface 
(Meizel, et al., 1991; Blackmore et al., 1991). P4-induced AR is inhibited by 17 - 
estradiol through interaction with a specific nongenomic estrogen receptor on 
sperm plasma membrane, suggesting that estradiol, which is present at 
micromolar levels in the follicular fluid, may act as a physiological modulator of 
P4 action on sperm assuring the appropriate timing of activation in the 
fertilization process.
F. Zona Pellucida
The Zona Pellucida is a porous and transparent extracellular glycoprotein 
matrix surrounding the female gamete, the thickness in the human is about 13 
pm, it contains both primary and secondary sperm receptors involved in species- 
specific development and plays a pivotal role in sperm-egg interactions. The 
characterization of the protein components of the ZP has been conducted in a 
variety of mammalian species, including the murine, porcine species, as well as 
human. The reported number of discrete proteins comprising the ZP from 
different mammalian species varies (Dunbar et al., 1981; 1994; Timmons and 
Dunbar, 1987; Bleil and Wassarman, 1980). In the mouse, it is clear that is 
composed of three sulfated glycoproteins, namely, ZP1, ZP2 and ZP3. ZP2 and
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ZP3 are present in about equimolar amounts in ZP, whereas ZP1 is present in 
much lower amount. These proteins play essential structural roles in assembling 
the extracellular coat during oogenesis. Each of these glycoproteins consists of 
a unique polypeptide that is heterogeneously glycosylated with both N-linked and 
O-linked oligosaccharides. Likewise, the human ZP is also composed of ZP1 
(90-110 kDa), ZP2 (64-76kDa), and ZP3 (57-63 kDa) (Shabanowitz and O’Rand, 
1988). The ZP is composed of very long, interconnected filaments of uniform 
width, ZP2 and ZP3 formed as a heterodimer filament construct, and ZP1 
provides the structural integrity of the zona pellucida by cross-linking these 
ZP2/ZP3 heterodimer within the filaments (Wassarman, 1988). This structural 
model for ZP is supported by the fact that transgenic mice homozygous for an 
insertional mutation in the ZP3 gene are unable to form a zona matrix despite the 
presence of ZP2 and ZP1 (Liu et al., 1996; Rankin et al., 1996). Wassarman 
(1999) pointed out that the ZP of eggs from a wide variety of mammals, including 
humans, is composed of a small number of glycoproteins that are closely similar 
to that of mouse ZP1-ZP3.
The mouse and human zona proteins share certain protein motifs that are 
conserved in other vertebrates. Each protein has a signal peptide that directs it 
onto a secretory pathway and a transmembrane domain near its carboxyl 
terminus, upstream of which (20-30 amino acids) is a basic amino acid cleavage 
recognition sequence (absent in human ZP1) for furin, a protease located 
ubiquitously in the trans-Golgi. The most striking degree of conservation among 
zona proteins is the signature zona domain: a 260 amino acid motif defined by
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
eight conserved cysteine residues that is present in several extracellular proteins, 
some of which participate in fibrillar matrices (Bork and Sander, 1992; Legan et 
al., 1997)
The ZP matrix has multiple functions during fertilization and 
preimplantation development. The ZP3 is responsible for species-specific binding 
of spermatozoa to the zona pellucida and for induction of the acrosome reaction 
(Wassarman, 1990; Saling, 1991). After ZP3-mediated acrosomal exocytosis, 
the spermatozoon is postulated to bind to ZP2 (Bleil et al., 1988). This step is 
required for the second step of sperm-zona pellucida interaction by maintaining 
the association of the spermatozoon with the zona as it progresses through the 
oocyte glycocalix. After fertilization, the ZP2 protein is modified in the ‘hardening 
reaction’ to prevent polyspermy. This modification is caused by cortical granule 
exocytosis. In general, it plays at least the following important roles during 
development: 1) it mediates initial sperm-egg recognition and induces acrosome 
reaction; 2) regulation of normal endocrine profiles during folliculogenesis; 3) 
formation of a barrier to heterospecific fertilization; 4) formation of a block to 
polyspermic fertilization in some mammals; and 5) protection of the embryo 
during preimplantation development (Benoff, 1997).
Genes homologous to the ZP2 and/or ZP3 genes have been cloned for 
the mouse (ZP3 and ZP2), hamster (ZP3), human (ZP3), rabbit (rc75), and 
marmoset (Ringuette et al., 1986; Liang et al., 1990; Kinloch et al., 1990; 
Chamberlin & Dean, 1990; Liang & Dean, 1993; Lee et al., 1993; Thillai-Koothan 
et al., 1993). In addition, genes that represent a third class of zona protein have
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been cloned from the rabbit (rc55) and pig (ZP3a) (Schwoebel et al., 1991; 
Yurewicz et al., 1993). Recently, full length ZP cDNAs from cat, dog and pig that 
are homologous to the ZP2/rc75 genes from mouse, human and rabbit, a full 
length zona pellucida cDNA from cat and a full length cDNA from human that are 
homologous to the rc55/ZP3a genes from rabbit and pig, and full length ZP 
cDNAs from cat, cow, dog, pig and rabbit that are homologous to the ZP3 genes 
from mouse, hamster, human and marmoset have been cloned and 
characterized (Harris et al., 1994). Genes encoding ZP2 and ZP3 are conserved 
among mammals and the DNA sequences of ZP3 cDNA coding regions show 
extensive homology between species studied so far.
The expression of the zona genes is restricted to oocytes. The coordinate 
transcription of zona genes is restricted to the two-week growth phase of 
oogenesis and serves both as a molecular marker for oocyte growth and 
differentiation. Virtually nothing is known about the mechanisms that restrict 
gene expression to the female germline, and although previously characterized 
transcription factors are present in oocytes, their target genes have yet to be 
determined. In the mouse, the promoters for these three zona genes contain 
potential binding sites for a variety of known transcription factors. Some binding 
sites are present upstream of one gene but not the others, or at significantly 
different distances from the transcription start sites.
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G. ZP3 and its biological functions
The genetic and molecular information of the zona pellucida proteins have 
been documented including the cDNA clone of human ZP3 that has been 
isolated and characterized from the loci of the human genome (Chamberlin, and 
Dean, 1990). The human ZP3 gene encodes a polypeptide of 424 amino acids 
(Chamberlin and Dean, 1990; Harris, 1994). The first 22 amino acids forms the 
putative signal peptide for the secretion of ZP3; there is a hinge region which 
spans amino acids 220 to 260; and near the end of the ZP3 polypeptide, there is 
a hydrophobic region (387-409). Among the three ZP proteins, ZP3 is the 
putative species-specific sperm-binding protein, is the most conserved between 
human and mouse. A single open reading frame encodes a protein that is 
identical in length with the mouse ZP3 protein and has a calculated molecular 
mass of 47,032 Da. The positions of all the 13 cysteine residues, as well as all of 
the recognizable domains of the mouse ZP3 polypeptide are conserved in the 
human ZP3 polypeptide. The human polypeptide chain contains four potential r e ­
linked glycosylation sites, three of which are conserved in the mouse; and sixty- 
six potential O-linked sites, 71% of which are conserved in the mouse 
(Chamberlin and Dean, 1990).
During fertilization in mammals, zona pellucida protein 3 (ZP3) is thought 
to be the primary zona protein that contributes to the initial sperm-egg recognition 
and induces sperm acrosome reaction. (Bleil and Wassarman, 1980; 
Wassarman, 1990; Wassarman, 1995). Only acrosome intact sperm binds to the 
ovulated egg in mouse, initial binding of spermatozoa to the zona pellucida is
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supported by ZP3 through) O-linked oligosaccharide side chains and 
complementary sperm-binding proteins present on the sperm plasma membrane. 
ZP-3 functions as the primary sperm receptor, experimental evidence strongly 
supports this conclusion in the mouse. Of the three glycoproteins that 
constitutes the ZP, only purified mZP3 binds exclusively to heads of acrosome- 
intact sperm, thus prevents sperm from binding to ovulated eggs in vitro (Bleil 
and Wassarman, 1980, 1986; Wassarman 1990). Even at nanomolar 
concentrations, purified, unfertilized egg mZP3 is very effective inhibitor of sperm 
binding in this competition assay. In a competition assay, the binding of a fixed 
amount of radioiodonated-ZP3 to acrosome-intact sperm was measured in the 
presence of unlabeled solubilized egg zonae pellucida (ZP1, ZP2, and ZP3). 
Increasing concentrations of the unlabeled zonae inhibited ZP3 binding. Bleil and 
Wassarman were thus able to conclude that there are a limited number of 
binding sites on the sperm head, for which the radiolabeled and unlabeled ZP3 
compete. On the other hand, at similar concentrations, mZP3 from fertilized 
eggs or early embryos has no effect on binding of sperm to eggs in vitro. This is 
consistent with the failure of free-swimming sperm to bind to the ZP of fertilized 
eggs and preimplantation embryos. Thus it can be concluded that mZP3 is 
altered due to zona reaction such that free-swimming sperm no longer can 
recognize and bind to the glycoprotein.
It has been postulated that ZP3 binding and ZP3-induced acrosomal 
reaction can be dissociated from each other because sperm binding and the 
acrosome reaction seem to represent two independent process (Kopf, 1990). A
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number of physiological and nonphysiological inducers of the acrosome reaction 
have been reported. These include progesterone, follicular fluid, and cumulus cell 
secretions containing prostaglandins, sterol sulfate, and glycosaminoglycans, 
and neoglycoproteins. However, it is now generally accepted that ZP3 is the 
natural agonist that initiates the acrosome reaction upon binding of acrosome- 
intact sperm to the ZP (Bleil and Wassarman, 1983; Florman et al., 1998). ZP3 
triggers a transduction pathway resulting in the fenestration and fusion of the 
sperm plasma membrane and the outer acrosome membrane at multiple sites of 
the anterior region of the sperm head, sequentially releasing the acrosomal 
contents at the site of sperm-zona binding and the exposure of the inner 
acrosomal membrane. It should be noted that the ability of mouse ZP3 (mZP3) to 
serve as an acrosome reaction inducer depends on the glycan moiety(ies) as 
well as on the polypeptide backbone of the molecule. Leyton and Saling (1989) 
did an ingenious experiment to show that ZP3 induced the acrosome reaction by 
aggregating the sperm membrane receptors for it. They capacitated mouse 
sperm and incubated them with fragments of ZP3 that could bind to the sperm. 
Although these fragments of ZP3 were bound, the acrosome reaction did not 
take place. However, when these fragments were crosslinked with antibodies 
against ZP3, the acrosome exocytosis occurred. Therefore, it appears that ZP3 
induces the acrosome reaction by crosslinking its receptors. Binding of sperm to 
ZP3 activates sperm G proteins and voltage-sensitive Ca2+ channels and results 
in a depolarization of the sperm membrane and a significant increase in 
intracellular Ca2+ levels.
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H. Carbohydrates
Carbohydrates are involved in fertilization through their addition to the 
protein core to form a glycoprotein which performs the specific functions. It is 
generally accepted that interaction of the opposite gametes is a carbohydrate- 
mediated receptor-1 igand event. Several sperm surface antigens from various 
species have been proposed to function as receptor molecules on acrosome 
intact spermatozoa. There are two types of glycosylations: N-linked and O- 
linked. For N-linked glycans, carbohydrates are linked to proteins through the 
nitrogen of asparagines. N-linked oilgosaccharides are thought to play role in 
protein secretion and dimerization of ZP protein (Sareneva, et al., 1994). In O- 
linked glycans, carbohydrates are linked to proteins through beta-hydroxyl 
groups of serine and threonine, and to less extent, of tyrosine, 5-hydroxylysine 
and 4-hydroxyproline, through a glycosyl-phosphotidylinositol anchor or through 
a carbohydrate-peptide chain (Benoff, 1997). There is overwhelming evidence 
that species-specific sperm-ZP interaction is a carbohydrate-mediated receptor- 
ligand binding event, which initiates a signal transduction pathway resulting in the 
exocytosis of acrosome content, ZP3 acts as the primary receptor for sperm, and 
the O-linked glycans but not the protein backbone, are responsible for the 
primary binding. It appears that the protein backbone does not play a direct role 
in sperm receptor function (Florman et al., 1984; Florman and Wassarman, 1985; 
Miller et al., 1992). Certain synthesized O-linked related oligosaccharides inhibit 
binding of sperm to eggs in vitro (Litscher, et al., 1995; Johnston et al., 1998). 
ZP2, on the other hand, acts as the secondary sperm receptor, binds to a trypsin­
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like proteinase associated with the sperm inner acrosomal membrane of the 
acrosome, and so makes the sperm bind more tightly to the zona pellucida (Bleil 
et al., 1988).
Extensive studies in the mouse have resulted in the identification of 
multiple receptors on spermatozoa and their complementary glycan units 
(ligands) on the homologous ZP (Tulsiani et al., 1997). The terminal sugar 
residues suggested to be recognized by the spermatozoa include mannosyl 
(Cornwall, et al., 1991), sialyl (lambert, 1984), glucosaminyl (Shur, 1993), a- 
galactosyl (Bleil et al., 1988), and b-galactosyl (Abdullah et al., 1989). Although a 
terminal fucosyl residue has not been implicated in mouse sperm-zona binding, 
its presence appears to be obligatory for an oligosaccharide to bind spermatozoa 
with high affinity (Johnston et al., 1998). Recent evidence from several 
laboratories (Johnston et al., 1998; Thaler et al., 1996) strongly suggests that 
sperm-egg binding leading to the acrosomal exocytosis is a complex event that 
likely reflects interaction between multiple sperm surface receptors and 
multivalent ZP3.
In the human system, in collaboration with other investigators, Dr. 
Oehninger has published numerous reports related to the involvement of 
carbohydrates (simple and complex) on human gamete interaction (Oehninger et 
al., 1990, 1991, 1992; 1995; Patankar et al., 1993). Initial studies were performed 
using hapten inhibition tests demonstrating the involvement of fucosylated and 
sialylated complex-type glycans (including probably biantennary-bisecting 
^structures) (Clark et al., 1995, 1996; Dell et al., 1995; Morris et al., 1996;
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Oehninger et al, 1998). More recently, we performed ZP lectin-binding, chemical 
treatment and enzymatic studies in order to assess the presence of 
carbohydrates on the human ZP. For the first time, we were able to provide 
direct evidence for the involvement of specific carbohydrate sequences (terminal 
sialic acid and other fucosylated and sialylated structures) in human gamete 
interaction (Patankar et al., 1997; Ozgur et al., 1998).
I. Putative zona binding proteins on sperm
Although several components have been suggested as putative sperm 
binding proteins on the surface of the male gamete, the identity and 
unambiguous function of these molecules remains to be elucidated. A number of 
ZP3-binding molecule candidates have been proposed including potential 
carbohydrate-binding proteins such as sp56, p95, p-1,4 galactosyltransferase 
and a-D-mannosidase (Bleil and Wassarman, 1990; Leyton and Saling,1989; 
Miller et al., 1992; Cornwall et al., 1991). However, these dada are from murine 
system, no persuasive data from human is available now.
Sp56 is one critical zona-binding protein of the murine sperm appears to 
be a protein that specifically binds to the galactose residues of ZP3. Bleil and 
Wassarman (1980) have shown that one of the critical carbohydrates of the ZP3 
glycoprotein is a terminal galactose group. If this terminal galactose is removed 
or chemically modified, sperm-binding activity is lost. These researchers later 
isolated this protein by binding ZP3 covalently to beads and passing the proteins 
isolated from mouse sperm membranes over them in a column (Bleil and
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Wassarman, 1990). Most of the proteins passed through the column, but one, a 
56-kDa peptide, bound to the ZP3-coated beads. It did not bind to ZP2-coated 
beads in a similar experiment. This protein was found to be exposed in the sperm 
membrane, and it bound to galactose residues, strongly suggesting that it is a 
sperm receptor binding to terminal galactose moiety on the ZP3 glycoprotein. 
Purified sp56 binds to the zona pellucida of unfertilized (but not fertilized) eggs 
and blocks sperm-egg binding (Bookbinder et al., 1995).
Galactosyltransferase is another sperm protein that appears to be 
important for sperm-zona binding is a sperm cell membrane glycosyltransferase 
enzyme. Shur’s laboratory has shown that this receptor for the zona is an 
enzyme that recognizes the sugar N-acetylglucosamine on ZP3 (Shur and Hall, 
1982; Lopez et al., 1985; Miller et al., 1992). This enzyme, N- 
acetylglucosamine:galactosyltransferase, is embedded in the sperm plasma 
membrane, directly above the acrosome, with its active site pointed outward. The 
enzymatic function of this 60-kDa enzyme would be to catalyze the addition of a 
galactose sugar (from UDP-galactose) onto a carbohydrate chain terminating 
with an N-acetylglucosamine sugar. The sperm surface galactosyltransferase 
appears to recognize a carbohydrate group on the ZP3 protein of the mouse 
zona pellucida. The aggregation of these galactosyltransferases causes the 
activation of a G protein that may be important in initiating the acrosome reaction 
(Gong et al., 1995). Sperm from mice that have this enzyme knocked out have 
impaired fertility. They are unable to undergo the acrosome reaction in response 
to ZP3 and they do not penetrate the zona well (Lu and Shur, 1997).
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Alpha-D-mannosidase is another sperm surface molecule that has been 
suggested as the potential sperm receptor. This enzyme has been identified in 
the plasma membrane of rat, mouse, hamster and human sperm (Tulsiani et al., 
1989; Chen et al., 1995). This enzyme differs from other mannosidase present in 
other tissues, including the mannosidase found in the acrosome (Tulsiani et al.,
1989)
The 95 kDa tyrosine kinase receptor is still a questionable candidate for 
ZP3 among different species. The 95 kDa tyrosine kinase receptor was first 
characterized in mice and has been shown to be phosphorylated in response to 
zona protein and to bind ZP3 directly (Leyton and Saling, 1989). In humans, a 
monoclonal antibody (mAb 97.25) has been shown to inhibit sperm-zona binding 
and immunoprecipitation experiments revealed that this antibody recognized a 95 
kDa phosphotyrosine-containing protein (Moore et al., 1987; Burks et al., 1995). 
A dual cloning strategy using the mAb 97.25 and anti-phosphotyrosine 
monoclonal antibodies was used subsequently to identify the cDNA (hu9 clone) 
encoding a novel human 95 kDa sperm tyrosine kinase receptor, named the 
zona receptor kinase (ZRK), and is presumed to be similar to the mouse protein 
(Burks et al., 1995). However, there has been much controversy regarding the 95 
kDa tyrosine kinase receptor/ZRK. It was reported to be a tyrosine- 
phosphorylated hexokinase in mice, but this has been disproved (Saling et al.,
1995). There is also much uncertainty about the cDNA of human ZRK, as the 
sequence exhibits close similarity to the proto-oncogene c-mer even though it is 
more closely related to mouse than to human c-mer (Bork et al., 1996). The fact
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that recombinant human ZP3 has also been shown to cause an increase in the 
tyrosine phosphorylation of a human 95 kDa protein is further evidence that such 
a moiety is somehow involved in initial gamete recognition (Burks et al., 1995; 
Brewis et al., 1998). Such zona-induced changes in tyrosine phosphorylation of a 
95 kDa have also been demonstrated unequivocally in cats (Pukazhenthi et al.,
1996). Therefore, it appears that this effect is conserved in mammalian 
spermatozoa and the 95 kDa protein remains the only human candidate for 
which there is evidence for interactions with ZP3.
J. Recombinant ZP3 production
Data from the mouse and pig demonstrate that the first stage of sperm- 
zona interaction is the binding of spermatozoa to ZP3 (Wassarman, 1992). 
Recombinant DNA technologies has revolutionized our understanding of many 
biological systems, consequently, the production of bioactive recombinant ZP3 
has raised great interest for several groups around the world. Cloning cDNAs 
encoding ZP3 has made the expression of recombinant ZP3 in tissue culture cell 
lines possible and represents a potential option to obtain large amounts of ZP3. 
The expression of biologically active recombinant ZP3 has been reported, at 
least, in the mouse (Kinloch et al., 1991; Beebe et al., 1992) and human (van 
Duin et al., 1994; Barratt et al., 1994; Burks et al., 1995). In the mouse, some of 
these proteins have demonstrated partial or full biological activity in ligand- 
receptor or acrosome reaction assays. Expression of recombinant ZPs is not 
restricted to those of the mouse and human species. Prasad et al., (1996)
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demonstrated that recombinant rabbit 55 kD protein (which is thought to be the 
rabbit homologue of mouse ZP1) purified from a baculovirus expression system 
could be used to generate a polyclonal antiserum which was then employed to 
study the localization of the native 55 kD protein in rabbit zonae. On the other 
hand, recombinant human ZP3 has been expressed using several approaches, 
i.e., Escherichia coli (Chapman and Barratt, 1996), in vitro transcription and 
translation (Whitmarsh et al., 1996), Chinese hamster ovary (CHO) cells (van 
Duin et al, 1994; Barratt and Hornby, 1995; Brewis et al., 1996) and in green 
monkey kidney (COS) cells (Burks et al., 1995). In the human, however, full 
biological activity has not been demonstrated, which is possibly due to 
inadequate or incomplete glycosylation of the recombinant protein (Chapman 
and Barratt, 1997).
With regard to the human system, production of a recombinant purified 
glycosylated ZP3 in a biologically active form is fraught with technical difficulties. 
In vitro transcription and translation systems and expression in Escherichia coli 
have led to the production of recombinant forms showing variable acrosome 
reaction-inducing activity. However, no direct or specific sperm-binding ability 
using homologous sperm-ZP bioassays have been reported for such non­
glycosylated products. In addition, protein solubility has been a major difficulty 
encountered (Chapman and Barratt, 1997). The CHO cell product has been 
shown to possess acrosome reaction-inducing activity. However, no data are 
available related to sperm binding in validated assays (van Duin et al., 1994;
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Whitmarsh et al., 1996). Again, this points to inadequate glycosylation of the 
protein core by the host cells.
In our previous studies, and considering that protein expression is tissue 
and species specific, human ovarian teratocarcinoma PA-1 cells were chosen as 
host cells. We have expressed and purified recombinant ZP3 and characterized 
its bioactivities. The rhZP3 from PA-1 cell has been demonstrated to possess 
both sperm binding activity and acrosome reaction inducing activity in human 
sperm (Dong et al., 2001). The binding activity was characterized by an indirect 
way by using the Hemizona Assay (HZA), and no direct binding of rhZP3 to 
human sperm has been demonstrated. This was the first report that showed 
rhZP3 had full spectrum of bioactivity as compared to the native zona pellucida.
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SPECIFIC AIMS
A. Significance of the proposed study
Male reproductive dysfunction accounts for about 30-50% of infertility 
cases and may represent the most common single defined cause of infertility 
(Irvine, 1999). Despite of the fact that contemporary therapies have enhanced 
the opportunities for infertile couple to have offspring, unfortunately, male 
infertility still remains a mystery, and it is considered “idiopathic” in a great 
proportion of cases. In order to understand and eventually treat male infertility, 
there arises a pressing need to uncover the “secrets" behind male infertility. An 
abnormal sperm-zona pellucida interaction is often observed in males with 
unknown infertility etiology. In the human, ZP3 is important as both a potential 
target for contraceptive vaccine development and as a possible tool in the 
diagnosis and treatment of male infertility. In order to explore this clinical 
potential of ZP3 and to study the cellular mechanism by which human 
spermatozoa becomes activated on making contact with ZP3, generating 
bioactive recombinant ZP3 is necessary. Defects of sperm-zona pellucida 
binding can be diagnosed in a high proportion of infertile men in the presence or 
absence of abnormalities of the basic sperm parameters (Oehninger et al., 1991,
1997). The Hemizona Assay (HZA) developed at the Jones Institute (Burkman 
et al., 1988) is currently widely used in the clinical arena to assess the direct and 
tight binding of sperm with the oocyte’s ZP. It is one of the most important 
functional tests for the assessment of sperm fertilizing capacity (Oehninger et
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al., 2000). The HZA evaluates the tight binding of sperm to the zona pellucida, a 
crucial step that triggers the physiological acrosome reaction leading to 
fertilization and early embryo development. The specificity of the interaction 
between human spermatozoa and the human zona pellucida in the HZA are 
being documented by the fact that the sperm tightly bound are acrosome reacted 
(Oehninger et al., 1991, 1993, 1997 and 2000). The HZA can be used as a test 
of choice for human gamete interaction of both sperm-zona binding and zona- 
induced acrosome reaction (Oehninger et al., 1992, 1993, 1995). However, the 
HZA is practically limited, because it requires a constant supply of human 
oocytes. Although sperm-zona pellucida binding and acrosome reaction 
bioassays have been validated in the clinical arena, the development of simpler, 
more standardized, and universally applicable diagnostic methods is warranted. 
Consequently, the development of bioassays based on the use of a recombinant, 
biologically active human ZP3 would have a tremendous impact in the diagnosis 
of male infertility. In this proposal, a fusion protein (GFP/ZP3) will be generated 
by molecular biology techniques, and subsequently applied in a sperm-zona 
pellucida binding test using the fluorescent protein as the marker. The results 
from this project will not only provide useful data for studying the feasibility of 
diagnosing male infertility by using recombinant human ZP3, but will benefit the 
study of gamete interaction mechanisms by using the recombinant protein.
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B. Rationale of the proposed research project
In mammals, fertilization takes place in the ampulla of the oviduct where 
individual gametes fuse to form a one-cell zygote. Mammalian gametes 
recognition and binding of spermatozoa to the egg is mediated by 
complementary molecules associated with the exterior of the egg and the sperm 
plasma membrane (Yanagimachi, 1994; Aitken, 1995). During mammalian 
fertilization, capacitated spermatozoa bind to the extracellular matrix of the egg 
(zona pellucida) and then undergo the acrosome reaction (AR). The AR is an 
essential exocytotic event which exposes the acrosomal contents and inner 
acrosomal membrane of the spermatozoon, allowing secondary binding, zona 
penetration and fusion with the oolemma. The predicted molecular masses of 
the protein cores of ZP proteins are about half of the apparent molecular mass of 
each ZP protein indicating significant post-translational modification. Much of 
this appears to be glycosylation that would permit the matrix to maintain a high 
state of hydration and may be important for sperm penetration through the zona 
pellucida. In-vitro biochemical studies have suggested functions for individual 
zona pellucida proteins in mice. ZP3 is considered the primary sperm receptor 
and induces sperm acrosome reaction after sperm bind to the zona pellucida. 
ZP2 is the secondary sperm receptor involved in the post-acrosomal induction 
binding. Due to the paucity of eggs for research, little is known about initial 
events of human sperm-egg recognition and induction of the AR. To obviate the 
problems of obtaining native human zonae, recombinant DNA technology has 
been used to produce zona proteins.
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To date, the expression of recombinant zona pellucida proteins (rZPs) 
from a range of mammals has facilitated the study of gamete interaction. The 
production of recombinant zona proteins has raised great interest among 
reproductive sciences investigators. Kinloch et al., (1991) first demonstrated that 
it was possible to express biologically active recombinant mouse ZP3 which can 
induce the sperm acrosome reaction. In the human system, cloning the human 
ZP3 gene (Dean, 1990) has facilitated the study of this glycoprotein in human 
gamete interaction. Recombinant human ZP3 has been successfully expressed 
through different approaches, such as in Escherichia coli (Chapman and Barratt, 
1996, Harris, 2000), in-vitro transcription and translation (Whitmarsh et al., 1996), 
in mammalian cell lines (van Duin et al., 1994; Barratt and Hornby, 1995; Dong et 
al., 2001).
The development of homologous functional bio-assay for sperm quality 
assessment has been a focal point of reproductive biologists. Burkman et al 
(1988) reported the hemizona assay (HZA), which used bisected human oocytes 
to assess the ability of sperm to bind to zona pellucida. The specificity of the 
human sperm-ZP interaction has been well documented (Oehninger et al., 1991, 
1993, 1995, 1997 and 2000). Up to now, the HZA still remains a reliable 
functional test of choice for human gamete interaction. Another sperm-zona test 
is called competitive intact zona pellucida binding test using oocytes that failed in 
IVF to determine a sperm-zona pellucida binding ratio between control and teat 
spermatozoa (Liu et al., 1988). The test is based on competitive binding of two 
sperm populations (test patient and fertile control sperm donor) to several
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oocytes. Test and control sperm are labeled with different fluorescent dye, which 
are FITC (green) and tetramethyl rhodamine isothiocyanate (red). Following 
labeling, sperm populations i.e. control and tests are simultaneously co­
incubated with several oocytes, after which zona binding is assessed by counting 
zona bound sperm under fluorescent microscopy. The fact that sperm-zona 
binding follows a dose-response curve can be employed in a clinical setting as a 
diagnostic tool to establish the sperm concentration, which will ensure optimal 
zona binding under IVF conditions. However, the current available sperm-zona 
binding test requires a constant supply of human oocyte. This is very time- 
consuming, and, therefore, the introduction of a valid sperm binding assay using 
recombinant ZP3 would have significant impact on male infertility diagnosis.
Upon the availability of full-length cDNA of human ZP3 (Chamberlin et al.,
1990), hZP3 expression has been conducted by different research groups. 
Despite several reports indicating the successful production of recombinant ZP3, 
no report has shown the rhZP3 to have direct binding activity with human sperm. 
Since glycosylation is crucial to the function of ZP3, the glycosylation level of in 
vitro expressed rhZP3 is an important aspect that has to be considered. Since 
gene expression is tissue- and cell specific, the glycosylation level also depend 
on cell type and species. In our previous study, after obtaining complementary 
DNA from mRNA isolated from human ovary, a biologically active recombinant 
zona pellucida protein 3 was produced by a human ovarian teratocarcinoma cell 
line (PA-1). The rhZP3 yield by our system showed similar biochemical 
characteristics to the native ZP3, including molecular size estimated by SDS-
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PAGE and recognition by a polyclonal anti-human ZP3 antibody. This rhZP3 
has been determined to possess both zona binding activity and acrosome 
reaction inducing activity (Dong et al., 2001). Again, the direct binding of rhZP3 
with human sperm has not been documented.
In the present study, we intended to generate a fusion protein between 
GFP and ZP3 and investigate its biological activities. GFP is a monomeric 
protein of 238 amino acids with molecular weight o f 27kD. A hexapeptide 
segment functions as a fluorescent chromophore that is formed upon 
crystallization of the residues Ser-dehydro-Tyr-Gly within the hexapeptide by 
post-translational modification. Since the chromophore forms automatically upon 
expression of the protein, and its fluorescence is highly stable and compatible 
with standard optics used to image fluorescein, GFP has rapidly gained 
popularity as a protein tag and cytoplasmic tracer dye (Steams, 1995). The 
project will focus on the characterization of direct binding activity of the fusion 
protein with human sperm. The fusion protein will combine the advantage of 
fluorescence characteristics of GFP and bioactivity o f ZP3, thus providing an 
option to detect sperm binding. A six-histidine tag fused to the target protein has 
been widely applied in recombinant technology to facilitate protein purification for 
subsequent application. (Sisk et al., 1994; Petty et al., 1996). The expression and 
purification technique is based on the remarkable selectivity of Ni-NTA (nickel- 
nitrilotriacetic acid) for proteins with an affinity tag o f six consecutive histidine 
residues — the 6xHis tag. The 6xHis tag is much smaller than most other affinity 
tags and is uncharged at physiological pH. It rarely alters or contributes to protein
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immunogenicity, rarely interferes with protein structure or function, does not 
interfere with secretion, rarely requires removal by protease cleavage, and is 
compatible with denaturing buffer systems. This 6*his tag has a strong affinity to 
a Ni ion on Ni-NTA resin under protein binding conditions, thus when it is linked 
with target recombinant protein at either the C- or N-terminal, the exposed 6*His 
on the protein backbone is able to bind with Ni ion on Ni-NTA resin. The target 
protein can be captured and enriched on the resin, thereafter, the protein 
molecules bound on the Ni-NTA resin can be eluted from the resin under 
stringent conditions, using high concentrations of imidazole to compete with the 
six-his tag for binding to the resin. In our study, we put the 6xHis tag at the N- 
terminal of human ZP3 sequence for purification.
C. Specific aims:
Studies in animal models have well established that the zona pellucida 
protein 3 (ZP3) not only serves as the putative primary ligand for receptor on 
sperm, but also acts as a physiological inducer of the sperm acrosome reaction. 
It is generally accepted that carbohydrate epitopes displayed by ZP3 play a 
pivotal role in spermatozoa-ZP3 interaction. Human ZP3 cDNA sequence has 
been elucidated and cloned, and a biologically active recombinant ZP3 (rhZP3) 
with partial activity has been successfully expressed by several groups. In 
previous studies, we expressed, cloned and purified rhZP3 using PA-1 cells as 
hosts, then characterized the sperm binding activities through indirect way by 
inhibiting zona binding with rhZP3 under hemizona assay (HZA) conditions;
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acrosome reaction agonistic activity of our rhZP3 was also identified (Dong et al., 
2001). Till present, only our group in vitro expressed a bioactive rhZP3 with 
complete activities. However, the direct binding of rhZP3 with human sperm has 
not been shown. Therefore we have faced two problems: (1) to prove direct 
binding activity, (2) to establish a bioassays predicting of sperm zona-pellucida 
binding. In this current proposal, a GFP tag will be fused with ZP3 at the N- 
terminus, the hypothesis is that the fusion protein GFP/ZP3: a) allow direct 
identification of the green fluorescence protein on the sperm surface; b) will 
possess bio-activity to interact with human spermatozoa. The overall goal of the 
project is to produce fusion protein GFP/ZP3, which can be used in testing the 
human sperm-oocyte binding. Therefore the following specific aims are 
proposed:
Specific aim 1: To clone and express the fusion protein GFP/ZP3 in vitro
1a: To subclone the human ZP3 gene into a pEGFP-C1 vector.
1b:To express the fusion protein GFP/ZP3 in human ovarian 
teratocarcinoma cells (PA-1).
Specific aim 2: To identify, isolate and purify the recombinant fusion 
protein GFP/ZP3 from the culture medium of transfected PA-1 cells
2a: To isolate and purify GFP/ZP3 using affinity chromatography.
2b: To identify the purified GFP/ZP3 by immunobloting.
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Specific aim 3: To characterize the direct binding activity of the fusion 
protein GFP/ZP3 to capacitated human spermatozoa, as well as its 
acrosome reaction inducing activity.
3a: To conduct flow cytometry to evaluate the binding of GFP/ZP3 to 
human spermatozoa.
3b: To apply fluorescence microscopy to visualize the binding of the fusion 
protein to human spermatozoa.
3c: To evaluate GFP/ZP3 as sperm acrosome reaction inducer.
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MATERIALS AND METHODS
A. Design and construction of oligonucleotide primers
The following oligonucleotide primers were designed, synthesized and 
used in the project. These oligonucleotides were synthesized by GIBCO Life 
Technologies INC. (Grand Island, NY). All the cloning sites and some special 
features of the primers were indicated in the sequence as shown below.
B1 and B2, which contain signal peptide sequence of ZP3 and six histidine were 
designed for annealing to form an oligo DNA sequence (B1B2), the latter was 
used for insertion right upstream to GFP sequence in the pEGFP-C1 vector. The 
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CH1 and CH2 were the primers used in our previous ZP3 subcloing (Chen,
1995).
B. Cell culture and medium collection
A human ovarian teratocarcinoma cell line, PA-1 was purchased from 
American Type Culture Collection (ATCC, Rockville, MD). PA-1 cells and stable 
transfected PA-1 cells were cultured in minimal essential medium (MEM, Sigma 
St. Louis, MO) supplemented with 5% Fetal Bovine Serum (FBS, Hyclone, 
Logan, Utah) and 100pg/ml geneticin (G418, Invitrogen, San Diego, CA) at 37 °C 
in 5% CO2 in humidified air; medium was changed every 24 hr. After three 
weeks, cells were amplified and transferred from a 100mm culture dish to 
150mm dishes. MEM containing 50% FBS and 5% DMSO (Sigma, St. Louis, 
MO) was used as a cytogenic medium for freezing the transfected PA-1 cells for 
the storage of cells (at -196 °C in liquid nitrogen). Since human ZP3 is a 
secreted protein, culture media from the stable transfected PA-1 cells were 
collected for further purification. Twenty-five 150 mm dishes were cultured and 
20 ml of medium were collected from each plate every 24 hr. The collected 
medium was then centrifuged at 1000xg for 10 minutes to remove cellular debris, 
and stored at 4°C with the addition of protease inhibitors including 100|ig/ml 
PMSF (Sigma), 2pg/ml Leupeptin (Sigma), Ipg/ml Pepstatin (Sigma) and 2mM 
EDTA (Sigma). The medium should be applied for purification within one week.
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C. Subcloning of pEGFP-ZP3 plasmid construct
The subcloning was accomplished in two steps, In the first step, two (i.e., 
B1 and B2) oligonucleotides which includes the restriction site, ZP3 signal 
sequence and 6xHis were synthesized, the oligos were annealed to form double 
strand DNA as follows: Dispense 100pl aliquots of the mixed oligos into PCR 
tubes. The tubes were placed in a thermal cycler and set up a program to 
perform the following profile: (i) heat to 95°C and remain at 95°C for 2 minutes, 
(ii) ramp cool to 25°C over a period of 45 minutes, (iii) proceed to a storage 
temperature of 4°C. Briefly spin the tubes in a microfuge to draw all moisture 
from the lid. The samples were pooled into a larger tube and stored on ice or at 
4°C until ready to use. After annealing the two oligonucleotides, the product 
B1B2 were digested with Nhel and Agel (New England Biolabs, Beverly, NA), 
then the digested B1B2 was ligated with pre-digested pEGFP-C1 vector 
(Clontech, Palo Alto, CA) with the same two enzymes. The ligation product was 
used for transformation; colony hybridization using radioactive probe and 
restriction enzyme digestion were used for the selection of possible positive 
clones. In the first-step subcloning, clone hybridization and restriction digest 
were applied to screen for E. coli clones with possible insertion of B1B2. Plasmid 
DNA (pEGFP-B1B2) isolated from the positive E. coli clone was utilized in the 
second step subcloning.
In the second step subcloning, a pentapeptide sequence (Asp-Asp-Asp- 
Asp-Lys) which can be recognized and cleaved by Enterokinase Max (Invitrogen, 
Carlsbad, CA) was inserted between GFP and ZP3, this procedure has several
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advantages: 1) to ensure the free rotation of GFP and ZP3; 2) to prevent the 
possible blocking effect of GFP on ZP3 folding; 3) Enterokinase Max can be used 
to cleave off GFP in the final fusion protein product when GFP interfere rhZP3 
binding with human spermatozoa. ZP3 sequence with Enterokinase Max 
sequence as well as cloning site were generated by PCR using A, C primer, ZP3 
cDNA generated from human ovary tissue (Chen, 1995) was used as the 
template to produce our target sequence in this experiment. The PCR product 
digested with Xhol and BamHI (New England Biolabs) was then ligated with 
predigested pEGFP-B1B2, as above described, the possible positive 
transformants were selected by clone hybridization, PCR and restriction 
digestion. Detailed human ZP3 DNA sequence and primer information is shown 
in the following figure (Fig. 1).
D. Ligation and transformation
DNA ligations were performed by incubating DNA fragments (B1B2 or ZP3 
DNA fragment from PCR) with appropriately liberalized cloning vector (pEGFP- 
C1), which has been digested with Nhel and Agel in the presence of buffer, 
rATP, and T4 DNA ligase (New England Biolabs). Ligations were done in a 10 
ul volume as follows: X vol of insert (approx. 25 ng), Y vol of digested vector 
(approx 6 ng), 1 ul of ligation buffer, dH20 to equal 9 ul, 1 ul of T4 ligase, 
overnight at 14°C. Meanwhile, the following ligation controls were set up: parallel 
ligations in the absence of insert DNA to determine the background clones 
arising from self-ligation. After ligation, transformation was performed: 1/2 of the
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Human ZP3 mRNA total cDNA 1-1299
________ m i  ^
1 TGCAGGTACC ATGGAGCTGA GCTATAGGCT „CTTC^TCTGC CTCCTGCTCT G^GTAGTAC 
start signal peptide
61 TGAGCTGTGC TACCCCCAAC CCCTCTGGCT CTTGCAGGGT GGAGCCAGCC ATCCTGAGAC
C sense
121 g t c c g t a c a g CCCGTACTGG TGGAGTGTCA GGAGGCCACT CTGATGGTCA TGGTCAGCAA
181 AGAC CTTTTT GGCACCGGGA AGCTCATCAG GGCTGCTGAC CTCACCTTGG GCCCAGAGGC
241 CTGTGAGCCT CTGGTCTCCA TGGACACAGA AGATGTGGTC AGGTTTGAGG TTGGACTCCA
301 CGAGTGTGGC AACAGCATGC AGGTAACTGA CGATGCCCTG GTGTACAGCA CCTTCCTGCT
361 CCATGACCCC CGCCCCGTGG GAAACCTGTC CATCGTGAGG ACTAACCGCG CAGAGATT C C
421 CATCGAGTGC CGCTACCCCA GGCAGGGCAA TGTGAGCAGC CAGGCCATCC TGCCCACCTG
481 GTTGCCCTTC AGGACCACGG TGTTCTCAGA GGAGAAGCTG ACTTTCTCTC TGCGTCTGAT
541 GGAGGAGAAC TGGAACGCTG AGAAGAGGTC CCCCACCTTC CAC CTGGGAG ATGCAGCCCA
601 CCTCCAGGCA GAAATCCACA CTGGCAGCCA CGTGCCACTG CGGTTGTTTG TGGACCACTG
661 CGTGGCCACA CCGACACCAG ACCAGAATGC CTCCCCTTAT CACACCATCG TGGACTTCCA
721 TGGCTGTCTT GTCGACGGTC TCACTGATGC CTCTTCTGCA TTCAAAGTTC CTCGACCCGG
781 GCCAGATACA CTCCAGTTCA CAGTGGATGT CTTCCACTTT GCTAATGACT CCAGAAACAT
841 GATATACATC ACCTGCCACC TGAAGGTCAC CCTAGCTGAG CAGGACCCAG ATGAACTCAA
901 CAAGGCCTGT TCCTTCAGCA AGCCTTCCAA CAGCTGGTTC CCAGTGGAAG GCCCGGCTGA
961 CATCTGTCAA TGCTGTAACA AAGGTGACTG TGGCACTCCA AGCCATTCCA GGAGGCAGCC
putative sperm binding site
1021 TCATGTCATG AGCCAGTGGT CCAGGTCTGC TTCCCGTAAC CGCAGGCATG TGACAGAAGA
1081 AGCAGATGTC ACCGTGGGGC CACTGATCTT CCTGGACAGG AGGGGTGACC ATGAAGTAGA
1141 GCAGTGGGCT TTGCCTTCTG ACACCTCAGT _GGTG_CTGCTG _GGCG_TAGGCC _TGGCTGTGGT
putative hydrophobic region 
1201 GG^GTCCCTG _ACTCTGACTG _CTGTTATCCT J^TTCTCACC AGGAGGTGTC GCACTGCCTC
^  CH2_______~
1261 CCACCCTGTG TCTGCTTCCG AATAAAAGAA GAAAGCAAT 
A antisense stop
Fig. 1. Human ZP3 sequence (Chamberlin and Dean, 1990) and the position of the primers used 
in the study.
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prepared ligation mixture and two controls were pipeted into eppendorf tubes. 
Competent cells (DH5a E. Coli cells) were plated alone on a selection plate as a 
negative control. The remainder of the ligation mix was stored at -20 °C and 
used as a back-up if necessary. The competent cells were placed directly on ice 
after removing from the -80 °C freezer. As the cells thawed, added 100 ul to each 
eppendorf tube containing the ligation products. The tubes were flicked to mix 
and placed immediately on ice for 30 minutes. Remove tubes from ice and 
incubate for two minutes at 37 °C in a water bath for a heat shock. Add 900 ul of 
sterile 1X LBM to each tube and continue incubating at 37 °C for 30 minutes. 
Plate 100-200 ul of each on LBM+ antibiotic using a glass spreader. Flame the 
spreader between plates and cool before each use. After inoculum has been 
absorbed (5 minutes) invert plates and incubate at 37 °C for 16 hours or until 
colonies were of the desired size. The remaining transformation culture was 
stored at 4 °C.
E. DNA isolation from E. Coli (mini prep)
After transformation of bacteria with the vector containing ZP3 sequence, 
bacteria were cultured for isolation of plasmid DNA. Inoculate 5 ml of LBM 
medium containing 50 pg /ml ampicillin (Sigma) with a single bacterial colony 
(transformed with vector containing ZP3 sequence) containing the desired 
plasmid. Bacteria were incubated at 37 °C overnight on a roller drum. Next day, 
cells were spun down at 2500 rpm in Beckman low speed centrifuge (e. g. the J- 
6) for 15 minutes. Each pellet was resuspended in 200 pi GTE solution and
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transferred to labeled eppendorf tubes. Incubated at room temperature for 5 
minutes. Add 400 pi of a freshly prepared solution of lysis solution. Mix gently. 
Place on ice for 5 minutes. Add 300 pi of an ice-cold solution of 3 M potassium 
acetate. Mix gently. Place on ice for 5 minutes. Centrifuge for 1 minute at 4 °C. 
Transfer the supernatant to a clean tube. Add 0.6 volume (540 pi) isopropanol to 
the supernatant mix and incubate at room temperature for 2 minutes. Pellet the 
nucleic acid (1 minute microcentrifuge spin top speed). Discard the supernatant. 
Wash the pellet twice with 1 ml 70% ethanol. Spin and dry the pellet for 10 
minutes in the lyophilizer or allow to air dry. Resuspend in 50 pi TE pH 7.5. Add 1 
pi of a 10mg/ml solution of RNAase and incubate for 30 minutes at room 
temperature. Assay the DNA on a mini gel with appropriate concentration 
standards before restricting digestion the DNA.
F. Preparation of labeled probe for colony hybridization
Thaw alpha-32P labeled dCTP (~1hr at room temp.) and also put on the 
heating for the 100 °C water bath. Denature 200 ng-1 mg oligonucleotide DNA 
(B1 which contains ZP3 signal peptide sequence and 6xHis) dissolved in 5-20 pi 
of dilute buffer in a micro centrifuge tube by heating for 5 min in a boiling water 
bath; then immediately cool on ice. Perform the following additions on ice: 1 pi 
10 mM dATP, 1 pi 10 mM dGTP,1 pi 10 mM dTTP, 20 pi 2.5X Random Primers 
Solution, 5 pi (approximately 50 pCi) [alpha-32P] dCTP, 3000 Ci/mmol, 10 Ci/pl , 
add distilled water to a total volume of 49 pi. Mix briefly. Add 1 pi of Klenow 
Fragment. Mix gently but thoroughly. Centrifuge 15-30 sec. Incubate at 37 °C for
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10 ~ 30 min. Add 5 pi Stop Buffer. Determine cpm using Scintillation counter. 
Use appropriate volume such that 5E6 cpm (2-4x105 cpm per membrane) is 
incorporated into probe.
G. Colony hybridization to identify the colony with B1B2 insert
Plate the transformation mixture onto selective medium plates and leave 
in hood with cover off until agar surface is dry. Incubate at 37 °C for 12-14 hours 
(smaller colonies give cleaner hybridization signals. First wet the autoclaved 
filters with dh^O and place between layers of Whatman paper. Then wrap in 
aluminum foil and autoclave at 15 Ibs/sq.in. When filter was completely wet stab 
agar with needle dipped in India ink in >3 places peripherally to make asymmetric 
markings.
Four pieces of Whatman 3 MM paper were pepared for colony lysis and 
DNA transfer; these papers were laid in a plastic tray then saturated each with 
one of the following solutions: a. 10% SDS, b. 0.5 N NaOH 1.5 M NaCI, c. 1.5 
M NaCI 0.5 M Tris-HCI pH 7.4, d. 2X SSC. Pour off any excess liquid for this 
will cause colonies to swell and blur subsequent hybridization signals. Peel the 
filter from the agar plate with blunt-tipped forceps and place upon the 10% SDS 
soaked paper colony side up. After three minutes transfer this to paper soaked in 
denaturing solution (b). After five minutes transfer to neutralizing paper (c). After 
five minutes transfer to paper soaked in (d). After five minutes of treatment with 
solution (d) dry the filters on dry 3 MM paper. Place filters between layers of 3 
MM paper and bake in a vacuum oven for 1-2 hours. Store dry or wash in 0.1X
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SSC 0.5% SDS at 65 °C for 30 minutes and store wet in seal-a-meal bags. Cross 
link the DNA under a UV light (Stratalinker). Rinse the filters in 2X SSC + 0.1% 
SDS on a rotator. Perform hybridizations as per the standard protocol. 
Prehybridize filters in a sealable bag containing pre-hybridization solution (25.0 
mM KH2PO4 , 5% Denhard’s solution, 50ug/ml salmon sperm DNA, and 50% 
formamide in 5x SSC buffer) at 42 °C for 3 hours by gentle shaking. Remove 
pre-hybridization solution from the bag and transfer the membrane to another 
bag containing hybridization solution (same as prehybridization solution, but 
omitting Denhart’s solution), the solution should be enough such that membranes 
move freely. Denature probe in boiling water for 5 minutes, rapidly chill on ice. 
Add the probe to the buffer. Incubate at 65 °C with constant shaking for 16hrs. 
Remove probe mix by pouring into 50 ml conical tube. Keep in freezer or discard 
in radioactive liquid waste container. Wash membrane with WSI in following 
sequence, monitoring with Geiger counter after each wash: 200 ml for 10 min. 
(discard in radioactive liquid waste) 200 ml for 10 min. For increased stringency 
(to decrease background) wash with WSII: 100 ml for 10 min. 200 ml for 10 min. 
Check membrane with Geiger counter. If background radioactivity is acceptable, 
allow filter to air dry between two 3MM Whatman filters (10-30 min.). Wrap 
membrane in Saran Wrap: develop in cassette with intensifying screen (white) in 
-70 °C freezer from 4 hr. to overnight.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4 4
H. Screen positive colony by PCR
Colonies were picked and put in 50pl PCR reaction mix (use new 
toothpick for each colony), boil 5' and spin briefly, add 0.5pl Taq Polymerase 
(2.5U) and overlay reaction with oil, amplify 30 cycles: 94 °C - 1', 42 °C - 2’, 65 °C 
- 4'. Do final extension at 65 °C for 5', check on an agarose gel.
I. DNA isolation from transformed E. Coli. (max prep)
In order to obtain a greater amount of plasmid DNA containing positive 
transformed clone for subsequent application, those positive clones were 
amplified. Grow 30 ml of culture overnight at 37 °C in the appropriate antibiotic 
media in a 250 ml conical flask (to allow sufficient aeration). Normal broth 
concentration needs 50pg/ml (i.e. 1/1000 dilution). Transfer to Oak Ridge tubes 
and harvest the cells by spinning down at 5000 rpm for 5 minutes (Beckman; JA- 
20 rotor, 4°C). The cells were resuspended in 2.5 ml GTE buffer (50 mM 
glucose, 10 mM EDTA, 25 mM Tris-HCI, pH 8.0). Add 100 pi of 40 mg/ml 
lysozyme (in GTE) and incubate for 10 minutes at ambient. Add 5 ml of 0.2 M 
NaOH/1 % SDS, mix by vortexing and incubate on ice for 10 min. Add 3.75 ml 
3M NaAcetate (pH 5.2) and vortex until a white precipitate forms. Incubate on 
ice for 15 minutes. Centrifuge for 15 minutes at 12,000 rpm. Transfer supernatant 
to a clean tube and add an equal volume of isopropanol. Incubate at ambient for 
10 minutes. Centrifuge at 12, 000 rpm for 15 minutes, pour off supernatant and 
invert the tubes over a clean tissue to remove the remaining isopropanol (pellet = 
DNA). Resuspend the pellet in 5 ml of 2 M NH4 Acetate and centrifuge at 12 000
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rpm for 10 minutes. Add an equal volume of isopropanol (5 ml) to supernatant 
and incubate at ambient for 10 minutes. Centrifuge at 12 000 rpm for 15 minutes. 
The pellet was resuspended in 0.4 ml SDW and transfer to a clean microfuge 
tube. Add 20 pi of 10 mg/ml RNAse (heat treated) and incubate for 15 minutes at 
37°C. Phenol extract the contents of the tube. Add 1710th volume of 3 M Na 
Acetate (40 pi), 2 volumes of 100 % ethanol and store tube at -20°C for at least 
1/2 hour. Pellet the DNA for 15 minutes in microfuge (14,000 rpm), remove the 
ethanol and wash two times with 70 % ethanol. Dry gently and check plasmid by 
agarose gel electrophoresis (load 1 pi of DNA on a 1 % agarose gel).
J. Stable transfection
The day before transfection, 2-8 x 10 5 cells were seeded in 5 ml 
appropriate growth medium in 60 mm dishes. The cells were incubated under 
37°C and 5% CO2 . On the day of transfection, 5 pg DNA (pEGFP-ZP3) 
dissolved in TE buffer pH 7 to pH 8 (minimum DNA concentration: 0.1 pg/pl) was 
diluted with cell growth medium containing no serum, proteins or antibiotics to a 
total volume of 150 pi. Twenty pi of SuperFect Transfection Reagent (QIAGEN, 
Valencia, CA) was added to the DNA solution. The samples were mixed well and 
incubated for 5—10 min at room temperature (15-25°C) to allow transfection- 
complex formation. While complex formation takes place, the growth medium 
was gently aspirated from the dish, and cells were washed once with 4 ml PBS. 
One ml of cell growth medium (containing serum and antibiotics) was added to 
the reaction tube containing the transfection complexes. The total volume were
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mixed well and immediately transferred to the cells in the 60 mm dishes. 
Incubated cells with the transfection complexes for 2 -3  h under 37 C and 5% 
CO2 . Medium containing the remaining complexes was removed from the cells 
by gentle aspiration, and washed cells 3-4 times with 4 ml PBS. Fresh cell 
growth medium (containing serum and antibiotics) was added, and incubated for 
24-48 h. Passage cells at 1:10 to 1:15 into the appropriate selective medium. 
Cells were maintained in selective medium under their normal growth conditions 
until colonies appear.
A positive clone was selected by culturing transfected cells in 800ug/ml of 
G418 (GIBCO, Grand Island, NY ) in MEM medium supplemented with 5% FBS 
for three months, single clone was picked, cultured in 96-well plate until each 
single cell form a single colony, then the cells grown in each were transferred to 
24 -well plate followed by transferring to 6-well plate, when the confluence in 
each well reached 70-80%, cells were trypsinized and harvested, some of which 
were used for isolation of cytoplasmic mRNA, and the rest were frozen for 
storage. The isolated mRNA from each colony was then subjected to RT-PCR 
test, flow cytometry analysis to verify fusion protein expression, furthermore, the 
culture medium was harvested and checked for the presence of GFP by Western 
blot using monoclonal anti-GFP antibody.
K. Isolation of mRNA
RNeasy mini kit (QIAGEN, Valencia, CA) was applied in mRNA 
purification from transfected PA-1 cells. Direct lysis transfected PA-1 cells in cell-
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culture dishes, add 1.0 ml of cold (4°C) RLT buffer (50 mM Tris Cl, pH 8.0, 140 
mM NaCI, 1.5 mM MgCfe, 0.5% (v/v) Nonidet P-40 (1.06 g/ml), just before use, 
add 1000 U/ml RNase inhibitor, 1 mM DTT). Gently using a rubber policeman to 
detach cells from the plates, and transferred to a centrifuge tube. Centrifuged 
lysate at 4°C for 5 min at 300-500 x g. Supernatant were transferred to an 
RNase-free 10—15 ml or 50 ml centrifuge tube, the pellet was discarded. After 
centrifuging, the pellet was warmed to 20-25°C, and appropriate volume of 
Buffer RLT was added. Mixed thoroughly by shaking or vortexing. Appropriate 
volume of ethanol (96-100%) was added to the homogenized lysate. Mixed 
thoroughly by shaking vigorously. The samples were applied to an Rneasy midi 
column placed in a 15 ml centrifuge tube. Centrifuge for 5 min at 3000-5000 x g, 
the flow-through was discarded, and centrifuge for 5 min at 3000-5000 x g. Add 
2.5 ml or 10 ml Buffer RPE to the RNeasy column. The column was washed 
twice by centrifugation. To elute, after transferring the RNeasy column to a new 
15-ml or 50-ml collection tube, appropriate volume of RNase-free water was 
directly added onto the spin-column membrane, after about 1 min, centrifuge for 
3 min at 3000-5000 x g. Repeat the elution step as described with a second 
volume of RNase-free water.
L. RT-PCR
First Strand cDNA Synthesis: The isolated mRNA was applied for reverse 
transcription to generate cDNA. The reverse transcription was performed as 
follows: A 20 pi reaction volume was set up for 1 pg of total RNA. Add the
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following components to a nuclease-free microcentrifuge tube: 1 pi 50-250 ng of 
random primers, 1ug Total RNA, Sterile, distilled water to 12 pi. Heat mixture to 
70 °C for 10 min and quick chill on ice. Collect the contents of the tube by brief 
centrifugation and add: 4 pi 5X First Strand Buffer (250 mM Tris-CI, pH 8.3, 375 
mM KCI, 15 mM MgCI2), 2 pi 0.1 M DTT, 1 pi 10 mM dNTP Mix (10 mM each 
dATP, dGTP, dCTP and dTTP at neutral pH). Mix contents of the tube gently 
and incubate at 42 °C for 2 min. Add 1 pi (200 units) of MLV reverse 
transcriptase, mix by pipetting gently up and down. Incubate 50 min at 42°C, 
then inactivate the reaction by heating at 70°C for 15 min. To remove RNA 
complementary to the cDNA, 1 pi (2 units) of E. coli RNase H was added and 
incubated 37°C for 20 min.
PCR Reaction: Only 10% of the first strand reaction was used for PCR.
The following was added to a PCR reaction tube for a final reaction volume of 
100 pi: 10 pi 10X PCR Buffer [200 mM Tris-HCI (pH 8.4), 500 mM KCI], 3 pi 50 
mM MgCb, 2 pi 10 mM dNTP Mix, 2 pi Amplification Primer 1 (10 pM), 2 pi 
Amplification Primer 2 (10 pM), 1 pi Taq DNA polymerase (2-5 U/pl), 2 pi cDNA 
(from first strand reaction, RNase H-treated), 80 ul Autoclaved, distilled water.
The reaction mixture was mixed gently and layered 2 drops (-100 ul) of mineral 
oil over it. Heated reaction to 94 °C for 3 min to denature. The PCR reaction was 
performed as follows: denature DNA template at 94 ° C for 1 minute, anneal at 
55 °C for 2 min, extension at 72 °C 1 min. Repeated cycles 34 times. A final 
extension step at 72 °C for 5 min. was performed to fill in any uncompleted 
polymerization. Then cooled down to 4-25 °C.
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M. SDS-PAGE and Western blot analysis
In order to confirm the identity of protein expressed in vitro, monoclonal 
antibodies against GFP (Clontech, Palo Alto, CA), 6xHis (Amersham,
Piscataway, NJ) as well as polyclonal antibodies against human specific ZP3 
peptide were used in Western Blot. The ZP3 antibody was produced by 
Biosynthesis (Lewisville, TX), which was raised from rabbit against a human 
specific ZP3 peptide (C-G-T-P-S-H-S-R-R-Q-P-H-V-M, ZP3 amino acid numbers 
327-340, Chamberlin and Dean, 1990). For Western blot analysis, firstly, SDS- 
PAGE was performed on 8% gels to separate protein samples. For each 
sample, total five micrograms of purified protein was combined with equal volume 
of 2x protein loading buffer (12.5 mM Tris, 4% SDS, 20% glycerol, 10% p- 
mercaptoethanol, 0.01% bromophenol blue, pH 6.8) and boiled for five minutes, 
electrophoresis was carried out at 200 constant voltage and is continued until the 
tracking dye run out of the gel. After gels resolved the samples, gels were then 
either stained with Coomassie brilliant blue G-250 (Sigma), or electrophoretically 
blotted onto Nitrocellulose membrane by using the Trans-Blot SD Semi-Dry 
Transfer Cell column (Bio-Rad, Mercules, CA). Membranes were blocked with 
blocking buffer (5% non-fat dry milk, 0.1% Tween-20 in PBS, pH7.4) overnight at 
4 °C with shaking. Primary antibody were diluted in the blocking buffer and 
incubated with the membranes for 1 hour at room temperature. Membrane was 
then washed with 0.4% Tween-20 in PBS for three times, each time 15 minutes. 
The membranes were then incubated with secondary antibody (anti-mouse IgG 
or anti-rabbit IgG) conjugated with Horse-Radish Peroxidase diluted in blocking
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buffer (1:3000) for 1 hour at room temperature. After three time 15 min washes 
with PBS/0.3% Tween-20 and three time 5 min washes with PBS/0.1 % Tween- 
20, the blots was developed using enhanced chemiluminescence detection with 
ECL kit (Amersham, Piscataway, NJ), according to the manufacture’s instruction.
N. BCA assay:
When each batch protein was isolated and purified from culture medium, 
the protein concentration was determined by a BCA assay kit from PIERCE 
(Rockford, IL). A standard curve using BSA was generated each time when 
measuring the protein concentration. BSA at the concentration of 0, 100, 200, 
300, 400, 500, 600, 700, 800, 1000, 1200pg/ml is prepared freshly. The BCA 
working solution was prepared by combining 5 ml of solution A and 100 pi of 
solution B, for both sample and standard protein, 12.5 pi was added to each well 
on a 96 well plate, duplicate samples were used, and 250 pi of BCA reagent was 
added to each well, the plate was thereafter incubated at 37 °C for 30 minutes; 
right after incubation, the microtiter plate was read at 570nm to get OD values of 
each standard and sample, finally the protein concentration was determined by 
the standard curve generated from the OD of BSA with serial dilutions versus 
BSA concentration.
O. Protein purification by affinity chromatography
The first step in isolation and purification is to ultra-filtrate cell culture 
medium to a small volume. An apparatus from Amicon (Bedford, MA) using a
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filter membrane with 30-kD molecular weight cut-off was applied to concentrate 
five hundred miniliters of culture medium to about 16-20 ml. The concentrated 
medium was then dialyzed against 5 liter of Ni-NTA binding buffer (50 mM 
Na2HPC>4, 300mM NaCI, pH 8.0) three times, with changing buffer every 12 
hours, the medium was then ready for protein purification.
A 6xHis sequence has been inserted right upstream to the fusion protein 
sequence to facilitate protein purification; therefore the affinity column Ni-NTA 
which specifically binds with 6xHis was applied for protein purification. All the 
procedures for protein purification were performed in cold room (4 °C). The resin 
from Qiagen (Valencia, CA) was packed on a column, ten volumes of Ni-NTA 
buffer was allowed to pass through the resin to equilibrate the resin. The 
dialyzed concentrated medium was then applied to the Ni-NTA column to pass 
through and collect “pass" fraction; the resin is then washed with 10 column 
volume (CV) of 5-8 mM of imidazole in binding buffer. Finally, elution with Ni-NTA 
buffer containing imidazole was performed to obtain bound protein on the resin.
P. Preparation of motile sperm and spermatozoa capacitation:
Sperm samples were obtained from healthy donors according to World 
Health Organization (WHO) standards. Semen samples donated for research 
have been approved by the Institutional Review Board at Eastern Virginia 
Medical School. Sperm samples were collected in the morning around 8-9:00 
am, and the quality of semen was assessed by the andrology lab. Freshly 
ejaculated spermatozoa from healthy donors were obtained by masturbation after
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at least 3 days of abstinence. After liquefaction by putting in 37 °C for at least 
thirty minutes, Computer-Assisted Sperm Analysis (CASA) was performed to 
assess spermatozoa motility and concentration. The Hamilton-Thom Research 
Sperm Analyzer was routinely used to evaluate sperm motion parameters. 
Samples having >40 million sperm/mL, >60% initial progressive motility and 
>14% normal morphology (strict criteria) were used in the experiments. 
Spermatozoa used in the experiment are motile and were selected by 
discontinuous centrifugation. Spermatozoa were isolated by discontinuous 
Percoll (Pharmacia, Peapack, NJ) gradient separation (90% and 40% layers) 
using human tubal fluid as diluent medium. Two milliliters of semen was carefully 
placed on Percoll layers, after centrifugation at 400xg for 20 minutes, purified 
population of highly motile (from 90% layer) is recovered, washed in HTF/0.5% 
HSA (Irvine Scientific, Santa Ana, CA) medium and centrifuged at 380xg for 10 
minutes. The supernatant was discarded, and the pellet was resuspended in 
HTF medium supplemented with 0.5% HSA. The final suspension was then 
readily subjected to motility analysis, generally, at least 90% motility should be 
obtained. Motion analysis was conducted after suspending sperm pellet in HTF 
medium, Then sperm samples was incubated at 37°C in 5% CO2 for 3 more 
hours in the same medium, to allow capacitation.
Q. Acrosome Reaction:
Sperm treated with GFP/ZP3 followed by acrosome reaction evaluation 
was performed to test the second bioactivity of GFP/ZP3. The sperm
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concentration for the immunofluorescence detection of acrosome reaction is set 
at 2 million motile sperm/ml. A series of 100 pi sperm aliquots (positive control: 
calcium ionophore A23187 at 5 pM; negative control: sperm culture medium; test: 
GFP/ZP3) will be prepared in Eppendorf vials and incubated in the 95% air, 5% 
CO2 37 °C incubator for 30 minutes. Triple slides were made for each assay. 
Hoechst 33258, a DNA-specific stain, that will enter the nuclear membrane of 
dead spermatozoa giving a fluorescent counterstain, was used for determination 
of viability (live sperm). Fluorescence isothiocyannate conjugated Pisum Satvum 
Agglutinin (FITC/PSA, Sigma, St Louis, Ml) staining techniques was employed to 
evaluate the acrosome status of spermatozoa in spot slides. The epifluorescent 
microscope will be used to read the spot slides at a power of 400 magnification, 
blind reading will be required for evaluation of immunofluorescence patterns and 
at least 100-200 cells from 10 random fields were evaluated per spot on the 
slide. In some experiments, solubilized human ZP was used as described in 
Cross et al, 1988, Mahony et al, 1991 and Franken et al, 1996. The results were 
expressed as percentage of live, acrosome-reacted spermatozoa in the total 
population counted.
R. Using flow cytometry to test the binding activity of GFP/ZP3:
Flow cytometry was employed to test the binding activity of GFP/ZP3 to 
acrosome-intact spermatozoa. The motile sperm were used in all experiments, 
in each test, sperm only and sperm incubated with recombinant GFP (5ug/ml; 
Clontech, Palo Alto, CA) were set as control. Motile sperm (2 million) were
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incubated with GFP or purified recombinant fusion protein GFP/ZP3 at 37 °C in 
5% CO2, 95% air for a certain time as needed in the experiment. The 
spermatozoa were then be divided into two aliquots, in which one as non-washed 
sample, the other will then be washed with PBS for two times, the wash was 
done by suspending the sperm pellet in 1 ml of PBS and centrifugation at 600g 
for 8 minutes. Both unwashed and washed sperm sample were resuspended in 
600ul of PBS for analysis by FACScan (Becton Dickinson Immunocytometry 
Systems, Mountain View, CA). Measurement was performed at a sample flow 
rate of 250-300 events/second and 15,000 events were analyzed for each 
sample. A gate was set on dot plot distributions of forward versus 90 degree 
scatter to exclude debris and clumps. Sperm that gave fluorescent signals above 
the control EGFP were considered to be positive. Data were expressed as the 
percentage of fluorescing sperm.
S. Assessment of the binding of GFP/ZP3 to human spermatozoa in Indirect 
Immunofluorescence Study
More than ninety percent motile spermatozoa were collected from 
capacitated human spermatozoa by the gradient Percoll centrifugation method as 
described above. Motile spermatozoa were incubated with recombinant 
GFP/ZP3 (20 pg/ml) in HTF containing 0.5% (w:v) HSA for 3 h (5% CO2 in air at 
37°C). Sperm aliquots were centrifuged at 800 x g for 5 min; the pellets were 
washed twice with PBS, then the pellets were spotted onto 8-well multitest slides 
(Cel-Line Inc., CA), air dried, and fixed with 1% paraformadehyde for 30 min for
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subsequent staining. The specimen was blocked with PBS containing 3% (w:v) 
BSA in a humidified box for 1 h at RT (all subsequent incubations were carried 
out at RT for 1 h). After washes with PBS, the specimen was then incubated with 
Alexa488 conjugated anti-GFP antibody (1: 200) for 1 hour. After three times of 
washes with PBS, the specimen was examined using a fluorescence microscope 
(Nikon, Garden City, NY) at x400 and x1000 magnification.
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RESULTS
A. Subcloning of human ZP3 cDNA sequence into pEGFP-C1 vector
The binding activity of the putative ZP3 has been demonstrated to be 
attributed to the C-terminus of ZP3 backbone, and the sequence responsible for 
the binding activity has also been identified in mouse, which is from amino acids 
329-334 (Chen et al., 1998). ZP3 is a secreted protein, and the signal peptide is 
vital for the protein secretion process as well as post-translational modification. 
Purification of recombinant ZP3 has been facilitated by inclusion of six-His tag at 
the C-terminal of ZP3, but still could not reach ZP3 with high purity and was not 
good enough for downstream study using rhZP3 (Dong et al., 2001). We want to 
in vitro express a fusion protein with ZP3, this fusion protein could provide a tag 
for detecting sperm binding, so green fluorescence protein (GFP) was selected 
for this study to fuse with human ZP3. Keeping the binding regions on ZP3 
backbone exposed to sperm was another issue that has to be concerned in 
expressing the fusion protein. Due to the above reasons, we have to fuse the 
ZP3 downstream to the C-terminus in order to maintain the binding activity of 
ZP3; the signal peptide sequence of ZP3 was put upstream to the GFP gene to 
allow the secretion of fusion protein. Since we do not know whether the protein 
conformation of the fusion protein will interfere the binding activity of ZP3 to 
human sperm, a proteinase was inserted between ZP3 and GFP; this will allow 
us to cleave off GFP in case the structure of fusion protein would disturb ZP3- 
sperm interaction.













Signal sequence (22 Aa) -  6 xHis
Fig. 2. The strategy of subcloning. The subcloning was accomplished in two steps. In the first 
step, two (i.e., B1 and B2) oligonucleotides which includes the restriction site, ZP3 signal 
sequence and 6xHis were synthesized, after annealing the two oligonucleotides, the product 
B1B2 were digested with Nhel and Agel, then the digested B1B2 was ligated with pre-digested 
pEGFP-C1 vector (Clontech, Palo Alto, CA) with the same two enzymes. The ligation product 
was used for transformation; clone hybridization using radioactive probe and restriction enzyme 
digestion were used for the selection of possible positive clones. Plasmid DNA (pEGFP-B1B2) 
isolated from the positive E. coli clone was utilized in the second step subcloning. In the second 
step subcloning, a pentapeptide sequence (Asp-Asp-Asp-Asp-Lys) which can be recognized and 
cleaved by Enterokinase Max (Invitrogen) was inserted between GFP and ZP3. ZP3 sequence 
with Enterokinase Max sequence as well as cloning site were generated by PCR using A, C 
primer, ZP3 cDNA generated from human ovary tissue (Chen, 1995) was used as the template to 
produce our target sequence in this experiment. The PCR product digested with Xhol and BamHI 
was then ligated with predigested pEGFP-B1B2.
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As such, the ZP3 subclonig was accomplished in two steps. The strategy of 
subcloning of the ZP3 gene into the pEGFP (enhanced green fluorescent protein) 
vector is outlined in Fig. 2.
A1: Insertion of the oligo B1B2 into the pEGFP-C1 vector
The general idea of this experiment is shown in Fig. 1. In the first step, 
synthesized oligonucleotide B1B2 (95 bps long) which includes the restriction 
site, ZP3 signal sequence and 6*His in that order were inserted into the pEGFP- 
C1 vector. Here, the introduction of a six-histidine sequence was for the purpose 
to facilitate later protein purification. Oligonucleotides B1 and B2 introduced Nhel 
and Agel respectively at 5’ and 3’ end for the insertion of annealed oligo DNA 
sequence B1B2 into pEGFP vector. The pEGFP-C1 vector was digested with 
Agel and Nhel, then the oligo DNA sequence B1B2 was inserted to the digested 
vector by ligation. The resultant plasmid construct was transformed into 
competent cells. Colony hybridization and PCR were employed to screen for 
possible positive clones with insert. Fig. 3 shows the results from colony 
hybridization, by using the radiolabelled (32P) B1 as probe; the dark dots 
represent possible clones with the insert of oligo sequence B1B2 into pEGFP-C1 
vector.
In order to further verify and select positive clone with the B1B2 sequence, 
DNA restriction digestion was conducted. Because the size of B1B2 is small (95 
bps), this will give some difficulty in visualizing the band on agarose gel, so 
instead of directly obtaining the 95 bps band, Nhel and another restriction 
enzyme site downstream to GFP sequence was selected to digest the plasmid to
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Fig. 3. Step I construct and screening positive colony by colony hybridization. The left and right 
panels were step I construct and colony hybridization respectively. Colony hybridization was 
applied to screen insertion of oligo DNA sequence B1B2 into pEGFP-C1 vector. A 32P labeled 
oligonucleotide B1 was used as probe to detect the presence of the insert; the strong dark dots in 
the picture indicated the possible successful outcome.
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obtain a DNA fragment which includes GFP and B1B2, therefore in this 
experiment, Nhel and Xhol were used to digest the plasmid with the insertion of 
B1B2. The original size of DNA sequence between restriction site Xhol and Nhel 
is 752 bps long, there are 9 bps between Nhel and Agel, after digestion the 
vector with Nhel and Agel, B1B2 (95 bps long) was inserted into digested vector, 
so when the positive plasmid with B1B2 insert was digested with Nhel and Xhol, 
the size of DNA sequence between these two sites should be 838 bps long. 
Those clones showing positive signal in colony hybridization were amplified and 
subject to plasmid DNA isolation, the isolated DNA was then digested with two 
enzymes (Nhel and Xhol), and an agarose gel was run to verify whether there 
was an insert of B1B2, vector only without insert was used as a control, plasmid 
isolated from a negative clone from colony hybridization was also used as 
another negative control. The picture below (Fig. 4) indicated two clones (shown 
on the left of the picture) had the insert of B1B2. The resultant positive clone 
was designated pEGFP-B1B2.
A2: Subcloning of ZP3 sequence without the signal sequence into pEGFP-B1B2 
Full length human ZP3 cDNA has been generated from total mRNA 
isolated from surgically removed human ovary using guanidinium thiocyanate 
extraction method in our previous study (Chen, 1995). Plasmid DNA isolated 
from the positive clones from step I was used in the step II subcloning. ZP3 
sequence with Enterokinase site right upstream to it was generated by PCR 
using primer A and C, the digested PCR product by restriction enzyme was 
inserted into pEGFP-B1B2 by ligation reaction. In turn, the ligated product was
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Fig. 4. Confirmation of the insertion of B1B2 by restriction digestion with Nhel and Xhol. The left 
two lanes represent two positive clones, the right two lanes represent sample from controls. 
There were two negative controls in the experiment, Lane 3: plasmid isolated from a negative 
clone from colony hybridization; lane 4: Vector only without insert.
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used in transformation to obtain positive E. coli clones with insert of ZP3 
sequence. In order to verify the integration of the target cDNA (human ZP3) into 
the vector pEGFP-B1B2, PCR using three pairs of primers (B1 and CH2, CH1 
and CH2, CH1 and A) was conducted. Fig. 5 showed the data from PCR of one 
clone with correct insert. Three pairs of primers were applied in the PCR to 
confirm the insertion of ZP3. Primers B1 and CH2, CH1 and A, CH1 and CH2 
were chosen to perform PCR, plasmid DNA from vector only was used as a 
negative control. With all three pairs of primers, one clone displayed strong 
signal showing positive insert of ZP3, the size from PCR was about 2070 bps, 
which is the size of combined sequence from GFP and ZP3, so it was concluded 
that ZP3 has been inserted into the vector. By now, the subcloning of ZP3 into 
pEGFP-C1 vector was successful and can be used in DNA sequencing to check 
if there is any mutation happened during subcloning. So before using the 
positive plasmid construct in transfection, DNA sequencing was performed to 
check the authenticity of inserted sequence, by comparison the sequence hZP3 
obtained from the positive clone with that of published, the result indicated the 
sequence was correct and identical to original published sequence (data not 
shown).
Therefore, based on the convincing results from PCR and DNA 
sequencing, it can be deduced that the human ZP3 cDNA has been correctly 
inserted into pEGFP-C1 vector and ready for transfection and expression in 
mammalian cells.






Fig. 5. Step II construct and the determination of the insertion of ZP3 cDNA by PCR. The 
insertion of ZP3 into vector pEGFP with B1B2 was verified by PCR using three pairs of primers 
(right). Vector only was used as the negative control. All three pairs of primers gave a bright 
band of approximately 2070 bps, which is the size of fusion protein GFP/ZP3.
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B. Stable transfection and expression of fusion protein GFP/ZP3
When the subcloning was completed, the plasmid DNA isolated from the 
positive clones was used for transfection into PA-1 cells with the aim to express 
fusion protein GFP/ZP3. Positive clones were selected by culturing cells in 
800pg/ml of G418 in MEM medium supplemented with 5% FBS, single clone was 
picked and amplified for RT-PCR test, flow cytometry analysis, furthermore, the 
culture medium was harvested and check for the presence of GFP by Western 
blot. A stable transfected human ovarian cell line was established by lipid- 
mediated transfection followed by antibiotic selection by growing the cells in 
medium containing G418. Total seven clones were later identified to be positive 
transfectants among those isolated single clones.
B1. Determination of the expression of GFP/ZP3 by flow cytometry and 
fluorescence microscopy
Firstly, in an easier and convenient way, flow cytometry was performed to 
identify the positive transfectants since a fluorescent marker (GFP) should be 
present inside the cells. In flow cytometry, measurements of cells or other 
biological particles are made as the cells or particles flow in single file in a fluid 
stream past optical and/or electronic sensors. Modern flow cytometers typically 
use lasers as light sources and measure light scattered by cells, which provides 
information about their size and internal structure, and fluorescence in several 
spectral regions emitted by dyes or labeled probes or reagents which bind 
specifically and stoichiometrically to cellular constituents such as antigens and 
nucleic acids. Flow sorting allows cells with pre-selected characteristics to be









A. Flow cytometry B. Fluorescence microscopy
Fig. 6. Determination of the expression of GFP/ZP3 by flow cytometry and fluorescence 
microscopy. Panel A: Flow cytometry of transfected PA-1 cells versus non-transfected cells. 
Total 15,000 cells were analyzed per sample. An obvious shift was observed in the transfected 
cell population. FL1 denotes fluorescence one, which in here is green fluorescence, the positive 
transfected cells shifts to the right of non-transfected cells due to the measurement of 
fluorescence from GFP/ZP3 inside the transfected cells. Panel B: Stable transfected PA-1 cells 
were grown on cover slips, and then the cells expressing GFP were visualized by fluorescence 
microscopy.
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diverted from the stream and collected for further analysis. With the 
characteristics of flow cytometry, it could be used to detect the green 
fluorescence and thereby differentiating positive transfectants with GFP/ZP3 from 
non-transfected cells. If the GFP/ZP3 was expressed in PA-1 cells, besides 
those proteins secreted into culture medium, green fluorescence would appear 
inside cells because of some retaining fusion protein inside the cells. A typical 
result from flow cytometry telling the difference between positive transfectants 
and non-transfected cells is shown in Fig. 6. The picture clearly demonstrated 
the expression of GFP/ZP3 in PA-1 cells, in the histogram overlay, FL1 denotes 
fluorescence 1, which in here is green fluorescence, the histogram of positive 
transfected cells shifts to the right of non-transfected ceils due to the 
measurement of fluorescence from transfected cells.
B2. RT-PCR to identify the expression of fusion protein GFP/ZP3
When the green fluorescence can be detected in the transfected PA-1 
cells, RT-PCR was conducted to further identify the expression o f fusion protein 
in PA-1 cells. Both cultured transfected and non-transfected cells were 
harvested for RNA isolation, the isolated RNA was then subjected to RT-PCR.
As shown in Fig. 7, RT-PCR using two pairs of primers A, C and CH1, CH2 was 
performed, non transfected PA-1 cells showed no signal, seven clones were 
found to show distinct specifically amplified sequence. Fig. 7 just showed the 
results from two of the seven clones, which displayed strong bands 
corresponding to approximately 1245 bps (ZP3) and 2070bps (EGFP/ZP3) 
respectively. Non-transfected PA-1 cells did not show any RT-PCR result. So
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Fig. 7. Verification of the expression of fusion protein GFP/ZP3 in stable transfected PA-1 cells 
with human GFP/ZP3 cDNA by RT-PCR. Clone 1 and 2 displays a high level of expression of 
ZP3/GFP by RT-PCR assay. Left panel: using primer A, C; Right panel: using CH1, CH2 primer. 
The GFP/ZP3 cDNA was used as positive control and non-transfected PA-1 cells (NT) for the 
negative control. Primer A, C amplified the sequence of ZP3 without signal peptide (22 amino 
acids, 66 bps), but with the sequence of Enterokinase (15 bps) and sequence of restriction 
enzyme sites (12 bps), plus trp (3 bps) and lys (3 bps), so the resultant size is 1245 bps. Primer 
CH1 and CH2 amplified the sequence of ZP3 and GFP.
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again, these RT-PCR results confirmed the expression of insert ZP3 as well as 
fusion protein EGFP/ZP3 in the mRNA level in the host PA-1 cells, and no hZP3 
mRNA was detected in the non-transfected cells.
B3. Western blot using monoclonal anti-GFP antibody to demonstrate the 
expression of EFGP/ZP3 protein
After positive RT-PCR results showing expression of mRNA of EGFP/ZP3 
was obtained, the expression of fusion protein at protein level also has to be 
confirmed. In order to demonstrate the production of recombinant fusion protein 
GFP/ZP3 in the transfected PA-1 cells and its secretion into the medium, western 
blot using monoclonal anti-GFP antibody was performed. Cultured cells were 
treated with lysis buffer to obtain protein from transfected cells; meanwhile, 
culture medium from transfected and non-transfected cells were harvested and 
the total protein from medium were precipitated down by 10% TCA method. The 
resultant protein from transfected cells lysis, transfected and non-transfected cell 
culture medium were applied to SDS-PAGE, after being transferred to 
nitrocellulose membrane, the protein samples on the membrane were probed 
with monoclonal anti-GFP antibody. The result is shown in figure 8, anti-GFP 
monoclonal antibody recognized a protein of about 90 kD in the cell lysis sample 
from transfected cells as well as sample from culture medium of transfected cells, 
no signal was identified in the non-transfected cells. The detection of GFP is 
very specific, since no background signal was picked up in the molecular weight 
ladder as well as in other sample. The 90kD protein detected in the sample from 
cultured transfected PA-1 cells is about the size of fusion protein (GFP/ZP3).
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Fig. 8. SDS-PAGE and western blot of non-purified fusion protein sample. The left and right panel 
represents SDS-PAGE and western blot respectively. In each panel, from left to right, molecular 
weight marker, cell lysis from transfected cells, partially purified protein from culture medium, 
medium from non-transfected cells. Monoclonal anti-GFP antibody was used in the western blot.
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The transfected cell lysis sample showed positive signal, which make sense and 
fit into our hypothesis, the production and secretion of GFP/ZP3 is actually a 
continuous process, so there should be some fusion protein present inside the 
cells. These results indicated that GFP/ZP3 was expressed in the transfected 
PA-1 cells.
Taken the convincing evidence from flow cytometry, RT-PCR and western 
blot together, it can be concluded that fusion protein GFP/ZP3 has been 
successfully expressed in the host PA-1 cells.
C. Purification of fusion protein from cell culture medium
As stated in the materials and methods section, a six-histidine was 
inserted upstream to the GFP to facilitate protein purification by Ni-NTA column. 
Protein with a six-His tag would bind strongly to the Nickle ion on the Ni-NTA 
resin, then the bound protein can be eluted from the resin by application of high 
concentration of imidazole to compete protein binding with nickel ion, and thus 
bound protein can be eluted from the column.
Before the purification of fusion protein GFP/ZP3, the culture medium from 
stable transfected PA-1 cells were subject to ultra-filtration to reduce the volume 
from 500ml to about 25 ml. Then the concentrated medium was extensively 
dialyzed against protein binding buffer so as to be ready for protein binding. The 
resultant medium was applied to equilibrated Ni-NTA resin. After protein bind 
with resin, the resin was washed with 4mM imidazole in protein binding buffer to 
remove non-specific bound protein from the resin. Firstly, a pilot experiment was
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Fig. 9. The sequential protein elute with different concentration of imidazole from Ni-NTA column. 
Lane 1-6: Molecular weight marker, 20mM imidazole elute, 40mM elute, 80mM elute, 100mM 
elute, 160mM elute, 200mM elute. Monoclonal anti-GFP antibody was used in the western blot.
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conducted to optimize the concentration of imidazole to be used for the elution of 
protein from column. Washed resin was eluted with a sequential elution buffer 
with different concentration of imidazole (20mM, 40mM, 80mM, 100mM, 160mM 
and 200mM). The eluted protein from each fraction was subjected to western 
blot to find out the optimal concentration of imidazole for elution through the 
identification of GFP in each fraction of protein. The result is shown in Fig. 9. 
This figure clearly indicated that fusion protein GFP/ZP3 started to come off from 
the resin under the condition with 40mM imidazole, and the protein seem to be 
elute from the resin in a step-wise way, with the increase of imidazole 
concentration, by using buffer containing imidazole from 40mM to 200mM, fusion 
protein can be eluted from the resin, but with the majority of protein eluted by 80 
to 160 mM of imidazole, and until 200mM imidazole was used, less protein left on 
the resin was eluted, which meant most protein has been eluted from the column 
by lower concentrations of imidazole. From this data, protein-binding buffer with 
200mM imidazole was applied for elution to completely remove protein from resin 
in subsequent experiment. And the eluted protein will be used in biological 
assays. By using the current protocol, the purity of our purified protein sample 
could reach 30-40%. (Fig. 10)
D. Identification of purified protein using western blot by three antibodies.
Upon the completion of partially purification, emphasis was placed to 
identify the purified protein by western blot to prove the presence of GFP, ZP3 
and 6xHis in the purified product. The anti-ZP3 antibody was generated by










Fig. 10. Purification of GFP/ZP3 by Ni-NTA affinity column. The left and right panel were SDS- 
PAGE and corresponding Western Blot result. Lane 1: Molecular weight marker; Lane 2: Purified 
sample.
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immunizing rabbit with a human ZP3 specific oligopeptide that spans 14 amino 
acids sequence at the C-terminus of ZP3 backbone. When using anti-ZP3 
polyclonal antibody from rabbit, a pre-immune serum from rabbit was also 
applied in parallel to the western blot to see whether there were some 
endogenous antibody from rabbit could recognize ZP3, no similar signal to that 
identified by anti-ZP3 serum was observed by pre-immune serum in the purified 
fusion protein sample (data not shown). So the specificity of the polyclonal anti- 
hZP3 antibody was proved to be very good even use this antibody at 1:5000 
dilution, the antibody can still recognize ZP3 and gave strong signal without any 
background signal. The fusion protein (GFP/ZP3) purified from the Ni-NTA 
column by affinity chromatography was then subject to western blot by three 
different antibodies (Fig. 11). In the blot using anti-6xHis antibody, a His ladder 
was used as positive control for the immunoblot as well as molecular weight 
marker. As it can be seen from the three blots, apparently, by using three 
antibodies, a single band corresponding to about 90kD was recognized in the 
purified sample. Therefore, western blot analysis using three antibodies (anti- 
GFP, anti-6xHis, anti-ZP3) strongly demonstrated the presence of GFP, ZP3 and 
6xHis in purified fusion protein. This gave solid evidence that fusion protein 
cDNA has been successfully integrated to the cell chromosome and produced 
correct protein that secured by our study. This is a further powerful support to 
the previous stable transfection and expression experiment.
An enterokinase site has been placed in between GFP and ZP3 
sequence, interest was taken to see whether the GFP tag can be cleaved off and





ZP3 antibody GFP antibody 6*His antibody
Fig. 11. Identification of GFP/ZP3 by three antibodies. Western blot of purified fusion protein by 
anti-human ZP3 polyclonal (left panel) and monoclonal anti-GFP antibody (center panel). In each 
panel, the left lane: purified fusion protein sample, the right lane: purified protein sample from 
non-transfected cell culture medium (NT). The right panel was the Western blot of fusion protein 
by monoclonal anti-6xHis antibody, a histidine protein ladder from QIAGEN was used as a 
positive control and molecular marker, a band of about 90 kD was observed in the purified fusion 
protein sample.
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result in separation of GFP and ZP3. So the enzyme digestion experiment was 
performed to address this issue. After enzyme digestion, western blot was 
conducted to check the digestion efficiency. The result is shown in Fig. 12. 
When using anti-ZP3 antibody, the uncut protein displayed a protein band at 
90kD, whereas to the digested protein, the protein recognized by ZP3 antibody 
was about 60~65kD, which is the size of putative human ZP3 itself.
As a summary to the above results, the expression and identification of 
fusion is complete, and the data has been proved to be very convincing.
E. Characterization of the biological activities of the fusion protein 
(GFP/ZP3)
During fertilization in mammals, zona pellucida protein 3 (ZP3) is thought 
to be the primary zona protein that contributes to the initial sperm-egg recognition 
and induces sperm acrosome reaction. (Bleil and Wassarman, 1980; 
Wassarman, 1990; Wassarman, 1995). There is overwhelming evidence that 
species-specific sperm-ZP interaction is a carbohydrate-mediated receptor-ligand 
binding event, which initiates a signal transduction pathway resulting in the 
exocytosis of acrosome content, ZP3 acts as the primary receptor for sperm, and 
the O-linked glycans but not the protein backbone, are responsible for the 
primary binding. It appears that the protein backbone does not play a direct role 
in sperm receptor function (Florman et al., 1984; Florman and Wassarman, 1985; 
Miller etal., 1992).
So far, we have successfully expressed the fusion protein GFP/ZP3, so 
whether this protein possesses biological functions was vital to us. So bioassay
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Fig. 12. Digestion of the purified fusion protein with enterokinse Max. In the picture, from left to 
right: un-digested purified GFP/ZP3, digested fusion protein sample and protein sample from non- 
transfected cells (NT), sample were probed with anti-ZP3 antibody.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
78
should be performed to characterize the functions of GFP/ZP3. In this study, we 
applied flow cytometry and immunofluorescence technique to prove the concept 
that the purified fusion protein would be able to bind to human spermatozoa. In 
addition, although not a primary goal of this present project, we also tested the 
acrosome reaction inducing activity of GFP/ZP3 on human spermatozoa.
E1: Human sperm binding activity
It was well documented that ZP3 on mammalian oocytes is responsible for 
two important functions: as a sperm ligand and inducer of sperm acrosome 
reaction. First, we want to characterize the binding activity o f the recombinant 
fusion protein GFP/ZP3. In the present study, flow cytometry and indirect 
immunofluorescence were applied to reach this specific aim. The semen 
samples used in the studies were from healthy donors unless otherwise 
indicated,
a. Flow cytometry
Taking advantage the GFP tag in the fusion protein, fluorescence 
activated cell sorting (FACS) can be used to identify if the fusion protein can bind 
to the human spermatozoa. 
a1. Sperm binding time course study
Based on preliminary study using flow cytometry to identify the binding 
activity of GFP/ZP3 to human spermatozoa, the results turned out to be 
promising. To further characterize the binding activity of the purified fusion 
protein, more detained studies were conducted. Firstly, a time course test for 
sperm binding was performed. The motile sperm samples were incubated with





Fig. 13. Time course study of sperm binding with GFP/ZP3. Human spermatozoa were 
incubated with fusion protein in the presence of binding buffer for different period of time. There 
was an increase of sperm binding as identified by flow cytometry with the increase of incubation 
time. Each value is the mean ±  SEM from three separate experiments.
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GFP/ZP3 for different period of time, the binding of sperm and GFP/ZP3 was 
measured after one, two and three hours of incubation. It should be noted that 
due to the long time preparation before FACS and the availability of FACS 
facility, the longest time can be tested was 3hrs. After purification, the 
concentration of fusion protein was expressed as the amount of GFP in the 
protein sample ([GFP] per batch of fusion protein). In the experiment, GFP only 
was used as negative control, for GFP only and fusion protein treated sperm 
sample, GFP concentration was normalized to be the same (final 5pg/ml of 
GFP), GFP only should show no binding, on the other hand, GFP/ZP3 show 
binding with sperm. Fig. 13 illustrated the relationship between incubation period 
of sperm with protein and its corresponding percentage of sperm showing 
binding. Fusion protein showed sperm binding, whereas GFP only showed no 
binding (data not shown here, but will be addressed later). It is clear that with the 
period of incubation increases, the percentage of binding sperm increases, so 
there is a time dependency for human sperm binding with fusion protein. 
a2. Dose dependency test
In order to determine how the concentration of fusion protein affect the 
binding of sperm with GFP/ZP3, a dose dependency assay was set up. Fig. 14 
shows the sperm binding test result obtained from FACS performed for dose test: 
1.0, 2.0, 3.0, 4.0, 5.0, 7.5, and 10.0, 12.5pg/ml of fusion protein. The result 
illustrates that there was a dose response for sperm binding with GFP/ZP3. The 
sperm binding increases with the increase of fusion protein concentration, and 
the binding curve starts to level off at around 5pg/ml of fusion protein GFP/ZP3.
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GFP/ZP3
Fig. 14. Dose dependency test of sperm binding with GFP/ZP3. A series of doses were applied 
to human spermatozoa, the binding was analyzed by flow cytometry. There was a dose- 
response for sperm binding with GFP/ZP3. The binding curve starts to level off at around 5ug/ml 
of fusion protein GFP/ZP3. Each value is the mean ± SEM from four separate experiments. One­
way ANOVA followed by LSD teat was used for statistics test. a indicated there was a significant 
difference compared with other samples (p<0.05).
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a3. Effect of enterokinase digestion of fusion protein on sperm binding test
An important issue in the experiment is to prove the binding of recombinant 
ZP3 to human sperm to be true positive, in other words, the binding is a 
biological phenomena, it is due to bioactivity of ZP3 but not result from artificial 
causes like some other co-purified protein in the sample which may physically 
help recombinant GFP/ZP3 adhere to the human sperm surface. To answer this 
question, Enterokinase Max was applied to digest purified fusion protein 
GFP/ZP3. A pilot study was conducted first to find out optimal conditions for 
complete digestion of fusion protein, for a certain amount of protein used in 
digestion, a series of different units of enzyme were used in the digestion, the 
digestion was completed in a 37 °C water bath; meanwhile, another sample with 
same amount of protein but with no enzyme added was used as a control to see 
if some protease acts at 37 °C to cleave fusion protein. Western blot using ZP3 
antibody was carried out to verify the efficiency of protein digestion. In Western 
Blot, besides all digestion protein samples, one sample with original undigested 
protein was used as a control to determine if fusion protein has been fully 
digested. In Fig. 15, the result from enterokinase digestion and the 
corresponding sperm binding test is shown. Two doses of enterokinse were 
used in digestion to find out if there was s dose effect on fusion protein digestion 
and then therefore sperm binding. From the western blot using ZP3 antibody, 1U 
of enterokinase completely cleave off GFP tag from fusion protein, and the sperm 
binding percentage decreased to 10%, while the undigested protein gave 53.6% 
binding sperm; for the 0.5U enterokinase digested protein sample, about 60%
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Fig. 15. Enterokinase digestion of fusion protein vs sperm binding test. Two doses of 
enterokinase were applied to the fusion protein; the digestion mixture was left at 37 °C for 
overnight. Then the undigested and digested proteins were used for the sperm binding test. The 
digested protein resulted in a decrease in sperm binding, complete digestion of fusion protein 
resulted in almost no sperm binding; furthermore, low dosage of enzyme resulted in incomplete 
digestion of fusion protein, and there were still about 20% sperm showing binding.
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Fig. 16. Determination of the effect of enzyme digestion buffer on sperm binding. The samples 
are as follows: 1, sperm; 2, GFP only; 3, GFP with digestion buffer; 4, uncut protein; 5, protein 
cut with 1 unit of enterokinase; and 6, protein with digestion buffer only. When GFP protein was 
used, digestion buffer only resulted in some non-specific signal (about 10% of sperm showing 
fluorescence). Wilcoxon ranked sign test was used for comparison of means of samples with 
different treatment. a indicated there was a significant difference compared with other samples 
(p<0.05).
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GFP was digested off from fusion protein, and the corresponding treated sperm 
sample showed 20% of sperm binding. These data indicated that the sperm 
binding analyzed by FACS is a ZP3 mediated phenomenon. There was a dose 
dependency relation between dose of enterokinase used and the sperm-binding 
outcome. One would ask why after complete digestion of fusion protein, the 
percentage of binding sperm did not return to basal line, which should be close to 
non-treated sperm only. It was postulated that the enzyme digestion buffer may 
some how create a certain level of background binding of sperm with GFP, to 
address this question, another experiment was performed. The result is 
illustrated in Fig. 16. As can be deduced from the data, GFP only with enzyme 
digestion buffer did give about 10% of background binding. However, there was 
no significant difference for sample treated with GFP and enzyme digestion 
buffer together and GFP only. A summary of the enzyme digestion vs sperm 
binding test is illustrated in Fig. 17, which is from four times repeat of same 
experiment. The result demonstrates that the sperm binding as assayed by flow 
cytometry using fusion protein GFP/ZP3 is mediated by ZP3.
A summary of the sperm binding activity of GFP/ZP3 test is outlined in 
Fig. 18. The same experiment was conducted for ten times to obtain the result 
as shown. The dose of GFP/ZP3 in this test was 5pg/ml, GFP (5pg/ml) only and 
NT + GFP were set as negative control. Sperm treated with GFP/ZP3 resulted in 
50.02 ± 4.51% binding, whereas GFP only and NT + GFP did not show any 
binding.
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Fig. 17. Summary of enterokinase digestion vs sperm binding test. Four times of enzyme 
digestion were conducted and the sperm binding test by flow cytometry was performed. The 
digested fusion protein showed a dramatic decrease of sperm binding in the test. There was 
some non-specific signal detected in the digested fusion protein sample when analyzed by flow 
cytometry. Each value is the mean ±  SEM from four separate experiments (n=4). Wilcoxon 
ranked sign test was used for comparison of means of samples with different treatment. a 
indicated there was a significant difference compared with other samples (p<0.05).
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Fig. 18. Sperm binding test by flow cytometry. One million of sperm were used in each sample, 
samples were as follows: 1, sperm only; 2, GFP alone; 3, GFP + NT; 4, GFP/ZP3. Fusion protein 
dose used in the test was 5pg/ml, GFP only and NT + GFP were used as negative control. Each 
value is the mean ±  SEM from ten separate experiments (n=10). Wilcoxon ranked sign test was 
used for comparison of means of samples with different treatment. a indicated there was a 
significant difference compared with other samples (p<0.05).
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b. Immunofluorescence to identify sperm binding
As an alternative approach, immunofluorescence was performed to directly 
visualize sperm binding with GFP/ZP3. Since when fusion protein was incubated 
with sperm, this could not give us visible signal under fluorescence microscope, 
this may be due to the low amount of protein expressed and isolated, or the 
green fluorescence has been quenched during protein purification. Therefore, to 
further demonstrate that GFP/ZP3 could bind to human sperm head region, we 
earned out immunofluorescence by amplifying the signal through the application 
of anti-GFP antibody. A typical binding pattern of the GFP/ZP3 to human sperm 
is shown in Fig. 19. After incubation n of sperm with GFP/ZP3, anti-GFP-Alexa 
488 was applied to stain the control and ZP3 treated human spermatozoa. With 
the treatment of GFP/ZP3, sperm showing binding to ZP3 was identified by 
observing green fluorescence over the sperm acrosome region, whereas sperm 
without ZP3 treatment showed no fluorescence. Again, this method ascertained 
the binding of GFP/ZP3 with human spermatozoa.
E2. Acrosome reaction induced by fusion protein GFP/ZP3
We also tested another activity of fusion protein GFP/ZP3 to act as sperm 
acrosome reaction inducer. A DNA dye Hoechst stain H33258 was applied to 
differentiate live/dead cells; only live cells were counted for computing sperm 
acrosome reaction percentage. Calcium ionophore A23187 was used a positive 
control; solubilized human zona pellucida (0.6ZP/pl) was also used as a positive 
control, due to the difficulty in obtaining human zona, solubilized human zona 
pellucida was only applied in acrosome reaction test once, so there was no error
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Fig. 19. Immunofluorescence microscopy to identify GFP/ZP3 binding with human sperm. After 
incubation of sperm with or without fusion protein, fixed sperm sample was probed with alexa 488 
conjugated anti-GFP antibody, which gave green fluorescence under fluorescent microscope. 
With the treatment of GFP/ZP3, some sperm showed binding with ZP3, which can be identified by 
the green fluorescence over the sperm acrosome region; those without GFPZP3 treatment and 
those treated with GFP alone did not show any green fluorescence.
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bar for HZP in the result (Fig. 20). Fusion protein gave a comparable acrosome 
reaction inducing activity to ZP; recombinant GFP/ZP3 could induce 19.16% (± 
3.44%) sperm acrosome reaction, which is significantly higher than the 
spontaneous acrosome reaction (10.87 ± 2.89%).
In summary, both biological activities of GFP/ZP3 have been 
characterized. Fusion protein has been demonstrated to possess complete 
biological activities of native ZP3 in as a ligand for human sperm receptors and 
sperm acrosome reaction inducer.
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Fig. 20. Acrosome reaction induced by recombinant fusion protein GFP/ZP3, Calcium ionophore 
and solubilized human zona pellucida (HZP) were used as positive control (n=4). Each value is 
the mean ± SEM from four separate experiments. Fusion protein could induce capacitated human 
spermatozoa to undergo acrosome reaction at 19.16% ± 3.44%, which is significantly higher than 
that of spontaneous acrosome reaction. Wilcoxon ranked sign test was used for comparison of 
means of samples with different treatment. a- b indicated there was a significant difference 
compared with other samples (p<0.05).
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DISCUSSION
Apart from a number of important steps in the fertilization process, the 
sperm-zona pellucida binding capacity of a given sperm population has been 
shown to be a crucial event during mammalian fertilization. The results of 
sperm-zona binding assays provide important evidence on the recognition event 
leading to fertilization (Franken et al., 1989, 1993; Gamzu, et al., 1994; 
Oehninger, 2000). Systematic examination of the interaction between sperm and 
zona pellucida has been the most promising of the new approaches. The 
development of homogenous functional bio-assay for sperm quality assessment 
has been a focal point of reproductive biologists. Originally, human sperm- 
oocyte interaction was defined in an assay developed to evaluate zona 
penetration; the methodology of this assay formed the cornerstone of the future 
sperm-oocyte interaction test (Overstreet et al., 1976). There are two well- 
established bio-assays that have the advantage of providing a functional 
homologous test for sperm binding to the zona pellucida, these two assays thus 
can compare populations of fertile and infertile spermatozoa in the same assay. 
These two methods are: Hemizona Assay (HZA) (Burkman et al., 1988) and a 
competitive intact zona pellucida-binding test (Liu et al., 1990).
The zona binding test is not widely used because of the difficulty in 
obtaining sufficient numbers of human zona. In theory the paucity of materials 
can be overcome by the production of recombinant proteins. Recombinant DNA 
technology made the production of larger quantities of protein in vitro feasible.
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There are strong evidence from mouse model which concluded that ZP3 was 
responsible for the primary binding, and ZP2 attributes to secondary binding 
(Wassarman, 1988, 1992), what’s more, recombinant DNA technology also 
demonstrate that in vitro expressed ZP3 and ZP2 possess the biological activities 
to bind to human spermatozoa (Whitmarsh et al., 1996; Tsubamoto et al., 1999). 
However no data are available related to sperm binding in validated assays. 
(Chapman, et al., 1996, van Duin, et al., 1994). There is a genuine need for the 
production of a recombinant human ZP3 that expresses the full spectrum of 
sperm binding and acrosome reaction induction of native ZP3. The production of 
a purified glycosylated recombinant human ZP3 in a biologically active form is 
fraught with technical difficulties.
The study carried out by our group has moved the rhZP3 production 
forward in that the rhZP3 has been characterized to possess binding activity and 
induce acrosome reaction (Dong et al., 2001). The successful production of 
biologically active rhZP3 by PA-1 cell line apparently closely resembles the 
native protein. In the present study, major objective was to characterize the 
sperm receptor activity of rhZP3, fluorescent dye has been widely applied in 
identification of molecule for different purpose in science; however, although 
through directly linking the fluorescent dye to ZP3 may allow the direct detection 
of binding of ZP3 with sperm, based on our previous experience work on ZP3, 
high background due to the difficulty and efficiency in removing free dye when 
preparing the fluorescent dye-tagged ZP3, and the results were not reproducible, 
these limit the application of ZP3 in the clinical diagnosis.
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The cloning of the wild-type GFP gene (wtGFP; Prasher et al., 1992; 
Inouye and Tsuji, 1994) and its subsequent expression in heterologous systems 
(Chalfie et al., 1994; Inouye and Tsuji, 1994; Wang and Hazelrigg, 1994) 
established GFP as a novel genetic reporter system. When expressed in either 
eukaryotic or prokaryotic cells and illuminated by blue or UV light, GFP yields a 
bright green fluorescence. The detection of GFP and its variants can be 
performed in living cells and tissues as well as fixed samples. GFP has been 
expressed as fusions to many proteins. In many cases, chimeric genes encoding 
either N- or C-terminal fusions to GFP retain the normal biological activity of the 
heterologous partner, as well as maintaining fluorescent properties similar to 
native GFP (Flach, et al., 1994; Wang and Hazelrigg, 1994; Marshall et al., 1995; 
Stearns, 1995). The use of GFP and its variants provide a “fluorescent tag” on 
the protein, which allows for in vivo localization of the fusion protein. GFP can 
provide enhanced sensitivity and resolution in comparison to standard antibody 
staining techniques (Wang and Hazelrigg, 1994).
The first specific aim of this present study was to express fusion protein 
GFP/ZP3 in PA-1 cells. As mentioned above, ZP3 has been demonstrated to be 
responsible for the primary binding of sperm with egg. The properties of GFP 
may provide an alternative way to give a fluorescent tag to ZP3, that is the 
fundamental idea in this study to in vitro express fusion protein GFP/ZP3, and 
consequently use it in the clinical diagnosis of male infertility. Thus by taking the 
advantage of the availability of green fluorescent protein, we expressed fusion 
protein GFP/ZP3 and then use this novel fusion protein to characterize ZP3’s
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sperm binding activity and eventually will try to develop a kit for diagnosing male 
sperm quality in clinical arena. The test may be used to predict fertilization 
failure and influence the decision to perform intracytoplasmic sperm injection as 
opposed to in vitro fertilization.
For fusion protein GFP/ZP3 expression, several points have been 
considered, first the fusion protein should be secreted; second, protein can be 
easier isolated and purified; third, the protein should present biological activity. 
Protein expressed inside the cell are sorted to different destination, ZP3 is 
secreted protein, and its secretion requires the signal peptide, which is a 22 
amino acids peptide. In the in vitro system, there are reports showing that using 
the signal sequence from another secreted protein, normally non-secreted 
heterologous protein was able to secret into the medium (Braspenning et al, 
1998). So in the experiment design, the original ZP3 secretion signal peptide 
sequence followed by a 6xHis sequence is inserted before the 5’ end of GFP 
sequence, the 6xHis sequence is used for protein purification by Ni-NTA affinity 
column.
The vector used in the expression of fusion protein includes the 
cytomegalovirus (CMV) intermediate early enhancer and the simian virus 40 
(SV40) promoter to generate high levels of expression on mammalian cells. 
According to the murine model, the binding site of ZP3 to sperm is located at the 
C terminal; therefore, to maintain the binding site exposed on the fusion protein, 
the 5’ end of ZP3 was fused with the 3’ end of GFP, as shown in Fig. 2; the 
signal peptide of human ZP3, with a six-histidine residue at its 3’ end, was
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inserted between the CMV promoter and the 5’ end of the GFP; the final 
construct was transfected into PA-1 cells, and treated with geneticin (G418) to 
obtain stable transfected cells.
Here, again, GFP shows its advantage in the selection of positive clones 
and monitoring the expression of fusion protein. As a live marker, GFP operates 
independently of cofactors and can be detected rapidly and easily. GFP fusion 
protein provides a versatile tool for tracking, identifying and purification of rhZP3. 
In cell culture, phenol-red free medium was used, the expression of fusion 
protein can be identified and tracked by reading the culture medium by a 
fluorometer, when the reading is higher, the protein yield is correspondently 
higher. Since the protein secretion is a continuous process, so we could actually 
still visualize the green fluorescing cell under fluorescence microscope. If the 
cells do not grow well, and the UV reading from cell culture remains very low, the 
medium will not be applied to protein purification. So GFP tag also provide a 
quality control of our culture system to monitor and ensure proper cell growth. 
However, we still keep in mind that the impact of 27kD protein on ZP3 structure 
and function has not yet been addressed, this will have to wait until purity of 
GFP/ZP3 increases to more than 80%, and protein structural study can be 
performed.
DNA sequencing of the subcloning product gave confident data showing 
that there was no mutation during subcloning of ZP3 cDNA into pEGFP vector, 
and the signal peptide of ZP3 was correctly put right upstream to the GFP 
sequence. The expression of GFP/ZP3 has been successful, as derived from
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the strong evidence from fluorescence miceoscopy photograph of cells 
expressing fusion protein GFP/ZP3, flow cytometry, RT-PCR and western blot 
using three antibodies, anti-GFP, anti-His, anti-ZP3. RT-PCR using two pairs of 
primers unequivocally demonstrates the mRNA expression of fusion protein, and 
the cDNA size inferred was correct, the size of cDNA for both ZP3 only and 
GFP/ZP3 were confirmed by this approach. Western blot using three antibodies 
gave a specific and strong band corresponding to molecular size of about 90kD, 
which is the size that adds those of ZP3 and GFP together. So the origin of 
translated protein was confirmed by the convincing western blot data. There is 
no doubt that we have obtained recombinant ZP3 with a GFP tag. This is 
fundamental and important for us because all the following experiments are 
based on this; in other words, an authentic in vitro recombinant ZP3 product is 
available for study in biological assay. We still face the problem to increase 
protein yield as well as purity. Since there is 5% of serum present in the culture 
medium, a serum free medium may be applicable in cell culture to decrease the 
co-purified protein. Meanwhile, cell growing in a large-scale apparatus such as 
bioreactor will eventually be set up to upgrade protein production. Cells will be 
grown in a suspension instead of monolayer on culture plate. The CMV promoter 
for increasing mammalian protein expression may be silenced or decreasing in 
efficiency with longer time of cell culture, this may be circumvented by replacing 
the CMV promoter by some other promoters that are more stable in promoter 
activity, the use of EF-2 promoter will be an option to fulfill this mission.
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Furthermore, GFP appears to increase protein solubility and stability 
(Rucker, et al., 2001; Waldo et al., 1999). Solubility has been a common 
problem in rhZP3 expression and purification for several groups (Chapman and 
Barratt, 1997). So through the production of fusion protein GFP/ZP3, the 
solubility problem may be circumvented. For long-term preservation of purified 
GFP/ZP3, more work need to be done to address this issue. When the yield 
reaches a certain high level, the protein can be lyophilized; or if the protein has to 
be stored in solution, the addition of some oligosaccharide can be the alternative 
option.
The data from protein expression provides us firm basis for the further 
development of a sperm function test using rhZP3. Next, Sperm receptor activity 
and acrosome reaction inducing ability of GFP/ZP3 were examined.
The study on human zona-sperm binding are restricted to the application 
of solubilized zona or oocyte (Morales et al., 1994; Henkel et al., 1995; Bastiaan 
et al., 1999; Henkel et al., 2001), this is due to the unavailability of recombinant 
ZP proteins with closest characteristics to the native zona proteins. As a result, 
little is known about the ZP-mediated signal transduction in the human.
Flow cytometry is a method for quantitating components or structural 
features of cells primarily by optical means. Although it makes measurements on 
one cell at a time, it can process thousands of cells in a fluid stream passing 
through the path of laser beams in a few seconds. Since different cell types can 
be distinguished by quantitating structural features, flow cytometry can be used 
to count a large population of single cells of different types in a mixture. In our
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study, we aimed to distinguish ZP3-bound and unbound sperm through the 
fluorescent tag linked to ZP3. So through flow cytometry, the basic two different 
populations of spermatozoa in the reaction system can be differentiated and the 
percentage of fluorescing sperm corresponding ZP3-binding sperm can be 
calculated. Under our experimental conditions, fusion protein GFP/ZP3 showed 
the activity to bind to human spermatozoa, the binding was demonstrated to be 
a time-dependent and protein dose dependent event, which fit in the biological 
phenomena. Furthermore, to prove whether the binding as detected by flow 
cytometry was the effect of ZP3, removal of GFP tag from fusion protein was 
conducted and the resultant sample was applied in the binding test, as it was 
expected, uncut fusion protein still showed about 50% sperm binding, but the 
GFP removed protein sample resulted in no sperm binding as analyzed by flow 
cytometry. Furthermore, different units of enterokinase were applied to digest 
fusion protein and the digestion efficiency was different, western blot was 
performed to check the digestion for reference in sperm binding test. When 
higher unit of enzyme was used, the enzyme completely cleaved off GFP from 
fusion protein, and the binding assay using this product gave negative result (no 
binding was observed); when less enzyme unit was used, only a portion of the 
fusion protein was digested, and accordingly, this digested fusion protein sample 
still resulted in human sperm binding but to a less level as compared with that of 
uncut fusion protein. Importantly, this experiment was repeatable. The consistent 
and reproducible binding test from protein enzyme digestion and its 
corresponding binding test clearly indicated that the binding of fusion protein with
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human spermatozoa identified by flow cytometry was a true result reflecting the 
activity of ZP3, but not from the artificial effect from GFP. So it can be inferred 
from these data that ZP3 can detect the putative sperm receptor on sperm 
plasma membrane.
Flow cytometry can characterize the binding activity of ZP3 with human 
sperm, but in the practical point of view, this approach may not be very useful, 
but at least it can be used to prove our hypothesis that the recombinant GFP/ZP3 
possess the biological binding activity to bind to human sperm. In order to give 
more direct evidence that identifying the binding between GFP/ZP3 and human 
sperm, immunofluorescence was conducted. Attempts to detect direct binding 
between sperm and ZP3 by fluorescence microscopy failed, this may be due to 
the fluorescence quenching during purification and the sensitivity of fluorescence 
microscopy was not good enough to capture the fluorescent signal on the sperm 
plasma membrane despite of the fact that fusion protein bind to the sperm; 
because we are still working very hard on protein purification, the purity and 
protein yield remains low, then another reason for undetectable fluorescence for 
binding can be the amount of the purified fusion protein was not high enough to 
give visible signal. By the time when protein purity and yield reaches a certain 
level, these problems will be automatically solved. Therefore, numerous trials 
were done to evaluate sperm binding by the amplification of fluorescence signal 
through fluorescent dye conjugated anti-GFP antibody, or by indirect 
immunofluorescence. Since GFP antibody is more versatile than ZP3, the GFP 
tag, again, gave us the privilege to use it as an epitope for sperm binding
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detection. The data from immunofluorescense gave us exciting result that with 
the treatment of fusion protein, human sperm displayed fluorescence over the 
sperm acrosome region, but not tail or post-acrosomal region; on the contrary, 
sperm without ZP3 treatment showed no fluorescence over acrosomal region. In 
practically all cases, motile sperm bound to the head region as revealed by 
immunofluoscence microscopy. Spermatozoa bind to the zona pellucida via the 
head region where complementary receptors for ZP3 are specifically located 
(Moore, 1995; Burks et al., 1995). The similarity in binding between zona and 
recombinant ZP3 strongly support that rhZP3 from our lab is biologically active 
and resemble that of the native zona. The result from immunofluorescence is in 
concert with flow cytometry to prove the binding activity of GFP/ZP3. Sperm 
binding assay using immnobead is also underway, form the preliminary data (not 
included in this dissertation), human sperm were found to be able to bind to the 
immunobead crosslinked with fusion protein, more work need to be done to find 
out best binding condition and result interpretation. Whitmarsh et al. (1996) 
evaluated their rhZP3 from in vitro transcription and translation by coating bead 
with rhZP3, the biological activity was expressed by using the percentage beads 
bound by capacitated sperm, however, and no further report is available. 
Although the data from our lab is still very premature, this approach is very 
promising; it can be very applicable when the method is set up.
A series of studies over the years have demonstrated that in murine ZP3 a 
small number of unique polypeptide sequences which are heterogeneously O- 
glycosylated are responsible for sperm-ZP3 binding. It has been postulated that
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recombinant proteins, which are glycosylated, may serve as better ligands for 
sperm receptor than non-glycosylated proteins. This may be due to the ability of 
glycosylated proteins to attain a more biologically appropriate conformation to 
complementary receptors on sperm plasma membrane. With the ability of 
recombinant proteins which lack carbohydrates to undergo successful binding to 
zona components (Zhu et al., 1997; Chapman et al., 1998) in vitro, as well as the 
ability of relevant transgenic/gene-ablated mice to undergo fertilization in vivo 
(Thall et al., 1995; Asano, et al., 1997), it is becoming apparent that, while 
carbohydrates may be involved in sperm-egg interactions, their absolute and 
essential role in primary sperm-egg binding still remains in question. Maybe the 
protein backbone of ZP3 has a more significant role to play in sperm binding and 
subsequent acrosome reaction in the human than the mouse. Despite the 
argument on the role of carbohydrates and protein backbone in ZP3 bioactivity, 
the fusion protein GFP/ZP3 has been proved to successfully expressed and 
contains the ZP3 polypeptide portion; and furthermore, the rhZP3 produced in 
our lab should be glycosylated, as the protein was expressed in mammalian 
cells, this can also be inferred from the molecular size of fusion protein (about 
90kD), if the protein is not glycosylated, the size would be only 72kD, which 
indirectly indicate the fusion protein is glycosylated, however it is certain that 
further evidence from glycosylation study need to be obtained in future 
experiments, this will have to wait until when recombinant protein of high purity is 
ready. With both carbohydrates and protein backbone of ZP3 present in the
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fusion protein product, the bioactivities characterized for the fusion protein in this 
study fit in well-documented bio-function of native ZP3.
The binding activity of recombinant zona proteins has also been 
demonstrated by some other groups, the N-terminal polypeptide portion of 
human ZP2 has been shown to contain a binding site for acrosome-reacted 
spermatozoa and to play an important role in secondary sperm binding and 
penetration into ZP (Tsubamoto et al., 1999); in bonnet monkey, purified 
recombinant ZPB from E coli. has been demonstrated to be able to bind to 
capacitated as well as acrosome-reacted spermatozoa (Covind et al., 2001). 
Interestingly, the proteins from these reports were from bacteria and thus non- 
glycosylated, whilst they still possess the activity to bind to sperm.
Recombinant fusion protein GFP/ZP3 can induce capacitated human 
sperm to undergo acrosome reaction. Induction of acrosome reaction was not 
observed when the rhZP3 was incubated with human spermatozoa for a short 
period of time (30 min). However, significant induction of acrosome reaction was 
observed with longer incubations (1 hr, up to overnight). At present, we can only 
speculate about these difference. The rhZP3 product, although able to initiate 
binding and an acrosome reaction, may not have been sufficiently close to the 
native molecule to induce a rapid acrosome reaction. Solubilized human zona 
pellucida could initiate high percentage of acrosome reaction (1ZP/ul) within 30 
min incubation (Franken, 1996, 2000). Experience use rhZP3 from other 
laboratories produced by CHO cells to initiate acrosome reaction was different. 
High levels of acrosome reaction (50%) could occur with short incubation times
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(30 min) (Barratt and Hornby, 1995; Brewis et al., 1996), while van Duin et al 
(1994) reported that overnight capacitation/or longer incubation periods with 
rhZP3 are necessary to achieve a significant response. Non-glycosylated rhZP3 
from in-vitro coupled cell-free transcription-translation system lacking pancreatic 
microsomes (Whitmarsh et al., 1996) or in Escherichia coli (Champan et al., 
1998) also induced the human sperm acrosome reaction, albeit at a considerably 
slower rate than its glycosylated homologue. To the fusion protein GFP/ZP3 
presented here, study on the comparison of non-glycosylated form from 
Escherichia coli and glycosylated form from PA-1 cells would be interesting. 
Further experiments examining induction of sperm acrosome reaction with 
GFP/ZP3 are necessary, such as dose response and varying the capacitation 
condition.
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CONCLUSIONS
1. Recombinant fusion protein GFP/ZP3 was successfully expressed in PA-1 
cells as demonstrated by flow cytometry, fluorescence microscopy, RT-PCR 
and immunoblotting.
2. The molecular weight of the expressed fusion protein was 90-92 kD, 
digestion of this protein by enterokinase further confirmed the successful 
protein expression as ZP3 of 65kD was identified in immunoblotting.
3. GFP/ZP3 showed binding activity to human spermatozoa as analyzed by flow 
cytometry and fluorescence microscopy.
4. The binding o f GFP/ZP3 to human spermatozoa was time- and dose- 
dependent.
5. When GFP was removed from fusion protein, the resultant product displayed 
no detectable binding in flow cytometry assay.
6. The protein was also able to induce human sperm acrosome reaction.
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